Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AASS 2.59 0 -1.35 5.0E-5 MirTarget; miRanda -0.3 0 NA
2 hsa-miR-590-3p ABAT 2.59 0 -0.34 0.43051 PITA; miRanda -0.27 0.00042 NA
3 hsa-let-7a-3p ABCA1 1.42 0 -0.71 0.00276 mirMAP; miRNATAP -0.28 0 NA
4 hsa-miR-361-5p ABCA1 0.97 0 -0.71 0.00276 miRanda; mirMAP -0.32 0 NA
5 hsa-miR-590-3p ABCA6 2.59 0 -2.84 1.0E-5 MirTarget; miRanda -0.47 2.0E-5 NA
6 hsa-miR-361-5p ABCA8 0.97 0 -5.33 0 miRanda -0.7 0.00034 NA
7 hsa-miR-590-3p ABCA8 2.59 0 -5.33 0 miRanda -0.89 0 NA
8 hsa-miR-590-3p ABCA9 2.59 0 -3.14 0 miRanda -0.71 0 NA
9 hsa-miR-590-3p ABCB1 2.59 0 -2.33 0 miRanda -0.29 1.0E-5 NA
10 hsa-miR-590-3p ABCB4 2.59 0 -1.92 0 miRanda -0.4 0 NA
11 hsa-let-7a-3p ABCC4 1.42 0 -1.54 1.0E-5 mirMAP -0.19 0.01906 NA
12 hsa-miR-590-3p ABCC4 2.59 0 -1.54 1.0E-5 mirMAP -0.25 2.0E-5 NA
13 hsa-let-7a-3p ABCC9 1.42 0 -2.76 0 mirMAP -0.65 0 NA
14 hsa-miR-590-3p ABCC9 2.59 0 -2.76 0 miRanda; mirMAP -0.64 0 NA
15 hsa-let-7a-3p ABCD2 1.42 0 -3.08 0 mirMAP -0.67 0 NA
16 hsa-miR-361-5p ABCD2 0.97 0 -3.08 0 miRanda -1.28 0 NA
17 hsa-miR-590-3p ABCD2 2.59 0 -3.08 0 MirTarget; miRanda; mirMAP -0.35 3.0E-5 NA
18 hsa-let-7a-3p ABCD3 1.42 0 0.14 0.52609 MirTarget -0.12 0.02959 NA
19 hsa-miR-590-3p ABHD2 2.59 0 -0.37 0.12248 miRanda; mirMAP -0.15 0.00026 NA
20 hsa-miR-125a-5p ABHD3 0.6 0.01023 0.98 0 PITA; miRanda -0.1 0.01012 NA
21 hsa-miR-590-3p ABI2 2.59 0 -0.65 0 miRanda; mirMAP -0.11 0 NA
22 hsa-let-7a-3p ABI3BP 1.42 0 -4.28 0 miRNATAP -0.98 0 NA
23 hsa-miR-181b-5p ABI3BP 2.49 0 -4.28 0 miRNATAP -0.74 0 NA
24 hsa-miR-590-3p ABI3BP 2.59 0 -4.28 0 miRanda -0.81 0 NA
25 hsa-miR-361-5p ABL1 0.97 0 -1.32 0 miRanda -0.32 0 NA
26 hsa-miR-125a-5p ABL2 0.6 0.01023 -0.32 0.04554 MirTarget; PITA -0.22 0 26766902 MicroRNA 125a 5p modulates human cervical carcinoma proliferation and migration by targeting ABL2; The direct regulation of miR-125a-5p on its target gene ABL proto-oncogene 2 ABL2 in cervical carcinoma was evaluated by quantitative real-time reverse transcription polymerase chain reaction Western blotting and luciferase reporter assays respectively; ABL2 was shown to be directly targeted by miR-125a-5p; In cervical carcinoma ABL2 gene and protein levels were both downregulated by miR-125a-5p
27 hsa-miR-15a-5p ABL2 2.35 0 -0.32 0.04554 MirTarget; miRNATAP -0.16 0 NA
28 hsa-miR-200c-3p ABL2 3.5 0 -0.32 0.04554 MirTarget -0.15 0 NA
29 hsa-miR-361-5p ABL2 0.97 0 -0.32 0.04554 mirMAP -0.15 0.00146 NA
30 hsa-let-7a-3p ABLIM1 1.42 0 -1.72 0 mirMAP -0.15 0.02468 NA
31 hsa-miR-590-3p ABLIM1 2.59 0 -1.72 0 miRanda; mirMAP -0.17 0.0006 NA
32 hsa-miR-361-5p ACACB 0.97 0 -2.93 0 miRanda -0.48 0 NA
33 hsa-miR-590-3p ACADSB 2.59 0 -1 0.00017 MirTarget; miRanda; mirMAP -0.19 5.0E-5 NA
34 hsa-miR-125a-5p ACAT1 0.6 0.01023 -1.05 0 miRanda -0.26 0 NA
35 hsa-miR-590-3p ACAT1 2.59 0 -1.05 0 mirMAP -0.13 0.00058 NA
36 hsa-miR-590-3p ACOT1 2.59 0 -0.69 0.00048 miRanda -0.21 0 NA
37 hsa-miR-590-3p ACOT2 2.59 0 -0.56 0.00263 miRanda -0.17 0 NA
38 hsa-miR-590-3p ACOX2 2.59 0 -3.75 0 miRanda -0.71 0 NA
39 hsa-miR-181b-5p ACSL1 2.49 0 -0 0.993 MirTarget -0.12 0.00517 NA
40 hsa-miR-181b-5p ACSS3 2.49 0 -2.48 1.0E-5 MirTarget -0.25 0.01051 NA
41 hsa-miR-590-3p ACSS3 2.59 0 -2.48 1.0E-5 miRanda -0.58 0 NA
42 hsa-miR-590-3p ACTB 2.59 0 -0.54 0.00046 miRanda -0.1 0.00016 NA
43 hsa-miR-125a-5p ACTBL2 0.6 0.01023 1.68 0.00368 miRanda -0.67 0 NA
44 hsa-miR-200c-3p ACTC1 3.5 0 -7.19 0 MirTarget -1.34 0 NA
45 hsa-miR-361-5p ACTC1 0.97 0 -7.19 0 miRanda; miRNATAP -3.21 0 NA
46 hsa-miR-590-3p ACTC1 2.59 0 -7.19 0 miRanda -1.76 0 NA
47 hsa-miR-125a-5p ACTG2 0.6 0.01023 -5.39 0 miRanda -0.51 0.00044 NA
48 hsa-miR-590-3p ACTG2 2.59 0 -5.39 0 miRanda -1.27 0 NA
49 hsa-miR-590-3p ACTN1 2.59 0 -1.05 0.00011 miRanda; miRNATAP -0.33 0 NA
50 hsa-miR-361-5p ACTN4 0.97 0 -0.06 0.65476 miRanda -0.18 1.0E-5 NA
51 hsa-miR-590-3p ACVR1 2.59 0 -0.44 0.01143 miRanda -0.2 0 NA
52 hsa-miR-361-5p ADAM12 0.97 0 0.88 0.05623 miRanda -0.82 0 NA
53 hsa-miR-590-3p ADAM12 2.59 0 0.88 0.05623 mirMAP -0.23 0.00464 NA
54 hsa-miR-125a-5p ADAM19 0.6 0.01023 -1.06 0.01895 mirMAP -0.65 0 NA
55 hsa-miR-361-5p ADAM19 0.97 0 -1.06 0.01895 miRanda -1.17 0 NA
56 hsa-miR-590-3p ADAM19 2.59 0 -1.06 0.01895 miRanda -0.23 0.00353 NA
57 hsa-miR-361-5p ADAM28 0.97 0 -0.73 0.15943 mirMAP -0.49 0.00113 NA
58 hsa-miR-590-3p ADAM32 2.59 0 -0.49 0.23688 miRanda -0.16 0.0295 NA
59 hsa-miR-590-3p ADAM33 2.59 0 -4.48 0 miRanda -0.8 0 NA
60 hsa-miR-590-3p ADAM9 2.59 0 -0.2 0.40665 miRanda; mirMAP -0.17 4.0E-5 NA
61 hsa-miR-181b-5p ADAMTS1 2.49 0 -3.81 0 miRNATAP -0.53 0 NA
62 hsa-miR-590-3p ADAMTS1 2.59 0 -3.81 0 miRanda -0.59 0 NA
63 hsa-miR-125a-5p ADAMTS14 0.6 0.01023 0.61 0.12479 miRanda; mirMAP -0.23 0.00478 NA
64 hsa-miR-590-3p ADAMTS14 2.59 0 0.61 0.12479 miRanda -0.14 0.03948 NA
65 hsa-miR-125a-5p ADAMTS15 0.6 0.01023 -2.81 0 mirMAP -0.81 0 NA
66 hsa-miR-590-3p ADAMTS16 2.59 0 -1.54 0.01905 miRanda; mirMAP -0.77 0 NA
67 hsa-miR-590-3p ADAMTS17 2.59 0 -1.24 0.00463 miRanda -0.2 0.01117 NA
68 hsa-miR-15a-5p ADAMTS18 2.35 0 -0.74 0.14599 miRNATAP -0.48 0 NA
69 hsa-miR-181b-5p ADAMTS18 2.49 0 -0.74 0.14599 miRNATAP -0.17 0.04646 NA
70 hsa-miR-590-3p ADAMTS18 2.59 0 -0.74 0.14599 PITA; miRanda; miRNATAP -0.43 0 NA
71 hsa-miR-15a-5p ADAMTS3 2.35 0 -1.18 0.00448 miRNATAP -0.53 0 NA
72 hsa-miR-200c-3p ADAMTS3 3.5 0 -1.18 0.00448 miRNATAP -0.41 0 NA
73 hsa-miR-590-3p ADAMTS3 2.59 0 -1.18 0.00448 miRanda; mirMAP -0.21 0.00422 NA
74 hsa-let-7a-3p ADAMTS5 1.42 0 -2.16 0 mirMAP -0.34 1.0E-5 NA
75 hsa-miR-15a-5p ADAMTS5 2.35 0 -2.16 0 miRNATAP -0.43 0 NA
76 hsa-miR-181b-5p ADAMTS5 2.49 0 -2.16 0 mirMAP; miRNATAP -0.25 1.0E-5 NA
77 hsa-miR-361-5p ADAMTS5 0.97 0 -2.16 0 PITA; miRanda -0.64 0 NA
78 hsa-miR-590-3p ADAMTS5 2.59 0 -2.16 0 PITA; miRanda; miRNATAP -0.4 0 NA
79 hsa-miR-181b-5p ADAMTS6 2.49 0 -0.88 0.01914 miRNATAP -0.13 0.03705 NA
80 hsa-miR-590-3p ADAMTS6 2.59 0 -0.88 0.01914 miRanda -0.27 6.0E-5 NA
81 hsa-miR-590-3p ADAMTS8 2.59 0 -4.33 0 miRanda -0.94 0 NA
82 hsa-miR-590-3p ADAMTS9 2.59 0 -1.79 0 miRanda -0.36 0 NA
83 hsa-miR-181b-5p ADAMTSL1 2.49 0 -2.52 0 miRNATAP -0.35 1.0E-5 NA
84 hsa-miR-590-3p ADAMTSL1 2.59 0 -2.52 0 miRanda; mirMAP -0.49 0 NA
85 hsa-let-7a-3p ADAMTSL3 1.42 0 -5.11 0 MirTarget -1.04 0 NA
86 hsa-miR-15a-5p ADAMTSL3 2.35 0 -5.11 0 MirTarget -1.2 0 NA
87 hsa-miR-590-3p ADAMTSL3 2.59 0 -5.11 0 miRanda -0.92 0 NA
88 hsa-miR-590-3p ADAMTSL5 2.59 0 -0.41 0.32739 miRanda -0.15 0.03422 NA
89 hsa-miR-125a-5p ADARB1 0.6 0.01023 -1.93 0 mirMAP -0.26 7.0E-5 NA
90 hsa-miR-181b-5p ADARB1 2.49 0 -1.93 0 MirTarget; miRNATAP -0.36 0 NA
91 hsa-miR-590-3p ADARB1 2.59 0 -1.93 0 miRanda; mirMAP -0.44 0 NA
92 hsa-miR-200c-3p ADCY2 3.5 0 -3.87 0 MirTarget; miRNATAP -0.44 0 NA
93 hsa-miR-361-5p ADCY2 0.97 0 -3.87 0 MirTarget; PITA; miRanda; miRNATAP -1.04 0 NA
94 hsa-miR-590-3p ADCY2 2.59 0 -3.87 0 mirMAP -0.75 0 NA
95 hsa-miR-15a-5p ADCY5 2.35 0 -5.17 0 MirTarget; miRNATAP -1.03 0 NA
96 hsa-miR-125a-5p ADCY9 0.6 0.01023 -1.5 0 mirMAP -0.32 0 NA
97 hsa-miR-181b-5p ADCY9 2.49 0 -1.5 0 miRNATAP -0.24 0 24269684 miR 181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 AC9 in cervical cancer cells; Phenotypic experiments indicated that miR-181b and AC9 exerted opposite effects on cell proliferation and apoptosis
98 hsa-miR-361-5p ADCY9 0.97 0 -1.5 0 miRanda -0.65 0 NA
99 hsa-miR-590-3p ADCY9 2.59 0 -1.5 0 miRanda -0.26 0 NA
100 hsa-let-7a-3p ADCYAP1 1.42 0 -3.51 0 miRNATAP -0.66 0 NA
101 hsa-miR-361-5p ADCYAP1 0.97 0 -3.51 0 miRanda -0.98 0 NA
102 hsa-miR-590-3p ADCYAP1 2.59 0 -3.51 0 MirTarget; PITA; miRanda; miRNATAP -0.71 0 NA
103 hsa-miR-590-3p ADD1 2.59 0 -0.81 0 MirTarget; PITA; miRanda; miRNATAP -0.14 0 NA
104 hsa-miR-125a-5p ADD2 0.6 0.01023 -0.72 0.25015 MirTarget; miRanda -0.88 0 NA
105 hsa-let-7a-3p ADD3 1.42 0 -0.66 0.00185 mirMAP; miRNATAP -0.14 0.00449 NA
106 hsa-miR-590-3p ADH1A 2.59 0 -4.53 0 miRanda -0.6 0 NA
107 hsa-miR-590-3p ADH1B 2.59 0 -7.89 0 miRanda; mirMAP -1.26 0 NA
108 hsa-miR-590-3p ADH1C 2.59 0 -3.38 7.0E-5 miRanda -0.46 0.00247 NA
109 hsa-miR-590-3p ADIPOQ 2.59 0 -5.02 0 PITA; miRanda; mirMAP -1.12 0 NA
110 hsa-miR-125a-5p ADM2 0.6 0.01023 2.23 0 mirMAP -0.21 0.0146 NA
111 hsa-miR-361-5p ADORA1 0.97 0 0.39 0.31104 miRanda -0.57 0 NA
112 hsa-miR-125a-5p ADPRH 0.6 0.01023 -0.71 0.00334 miRanda -0.21 3.0E-5 NA
113 hsa-miR-361-5p ADRA2A 0.97 0 -2.58 0 miRanda -0.88 0 NA
114 hsa-miR-15a-5p ADRB2 2.35 0 -1.96 1.0E-5 MirTarget -0.26 0.00282 NA
115 hsa-miR-125a-5p ADRB3 0.6 0.01023 -5.02 0 miRanda -0.38 0.00257 NA
116 hsa-miR-125a-5p AEN 0.6 0.01023 -0.36 0.01541 miRanda -0.12 0.00013 NA
117 hsa-miR-590-3p AFAP1 2.59 0 -0.98 0.00012 PITA; miRanda; miRNATAP -0.22 0 NA
118 hsa-miR-125a-5p AFAP1L2 0.6 0.01023 0.06 0.85809 miRanda -0.14 0.03234 NA
119 hsa-miR-181b-5p AFF1 2.49 0 -0.53 0.00163 mirMAP; miRNATAP -0.11 0.00021 NA
120 hsa-let-7a-3p AFF2 1.42 0 -1.73 0.00201 mirMAP -0.29 0.02983 NA
121 hsa-miR-590-3p AFF2 2.59 0 -1.73 0.00201 PITA; miRanda; mirMAP; miRNATAP -0.25 0.01122 NA
122 hsa-let-7a-3p AFF3 1.42 0 -5 0 MirTarget -1.07 0 NA
123 hsa-miR-200c-3p AFF3 3.5 0 -5 0 MirTarget; miRNATAP -0.59 0 NA
124 hsa-miR-590-3p AFF3 2.59 0 -5 0 PITA; miRanda; mirMAP; miRNATAP -0.79 0 NA
125 hsa-miR-15a-5p AFF4 2.35 0 -0.82 0 MirTarget; miRNATAP -0.13 2.0E-5 NA
126 hsa-miR-181b-5p AFF4 2.49 0 -0.82 0 mirMAP; miRNATAP -0.12 0 NA
127 hsa-miR-361-5p AFF4 0.97 0 -0.82 0 miRanda -0.1 0.02408 NA
128 hsa-miR-590-3p AFF4 2.59 0 -0.82 0 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.11 2.0E-5 NA
129 hsa-miR-181b-5p AGFG2 2.49 0 -0.51 0.00539 mirMAP -0.11 0.00068 NA
130 hsa-miR-590-3p AGL 2.59 0 -0.67 6.0E-5 PITA; miRanda; mirMAP; miRNATAP -0.12 6.0E-5 NA
131 hsa-miR-125a-5p AGPAT4 0.6 0.01023 -0.79 0.01174 miRanda -0.26 9.0E-5 NA
132 hsa-miR-15a-5p AGPAT4 2.35 0 -0.79 0.01174 mirMAP -0.18 0.0035 NA
133 hsa-miR-361-5p AGPS 0.97 0 -0.1 0.48101 miRanda; miRNATAP -0.13 0.00105 NA
134 hsa-miR-590-3p AGT 2.59 0 -1.62 0.00168 miRanda -0.31 0.0007 NA
135 hsa-miR-590-3p AGTR1 2.59 0 -4.49 0 miRanda -1.09 0 NA
136 hsa-miR-125a-5p AGTRAP 0.6 0.01023 0.96 0 miRNAWalker2 validate; miRanda -0.1 0.01113 NA
137 hsa-miR-361-5p AHNAK 0.97 0 -1.66 0 miRanda -0.55 0 NA
138 hsa-miR-590-3p AHNAK 2.59 0 -1.66 0 miRanda -0.32 0 NA
139 hsa-miR-361-5p AIDA 0.97 0 -0.31 0.01307 miRanda -0.22 0 NA
140 hsa-miR-361-5p AJAP1 0.97 0 -1.65 0.0004 miRanda -0.38 0.0057 NA
141 hsa-miR-590-3p AK5 2.59 0 -1.18 0.03248 miRanda; mirMAP -0.21 0.02614 NA
142 hsa-let-7a-3p AKAP11 1.42 0 -0.8 0 mirMAP -0.16 4.0E-5 NA
143 hsa-miR-125a-5p AKAP11 0.6 0.01023 -0.8 0 miRanda -0.1 0.00318 NA
144 hsa-miR-15a-5p AKAP11 2.35 0 -0.8 0 MirTarget; miRNATAP -0.13 4.0E-5 NA
145 hsa-miR-361-5p AKAP11 0.97 0 -0.8 0 mirMAP -0.16 0.00083 NA
146 hsa-miR-590-3p AKAP11 2.59 0 -0.8 0 MirTarget; miRanda; miRNATAP -0.17 0 NA
147 hsa-let-7a-3p AKAP12 1.42 0 -2.95 0 miRNATAP -0.59 0 NA
148 hsa-miR-361-5p AKAP12 0.97 0 -2.95 0 miRanda -0.63 0 NA
149 hsa-miR-590-3p AKAP12 2.59 0 -2.95 0 miRanda; mirMAP -0.41 0 NA
150 hsa-miR-125a-5p AKAP13 0.6 0.01023 -1.15 0 miRanda -0.18 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 471 1672 2.058e-46 9.574e-43
2 REGULATION OF CELL DIFFERENTIATION 427 1492 9.982e-44 2.322e-40
3 NEUROGENESIS 403 1402 1.181e-41 1.832e-38
4 BIOLOGICAL ADHESION 320 1032 6.063e-40 7.052e-37
5 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 446 1656 2.117e-38 1.429e-35
6 CARDIOVASCULAR SYSTEM DEVELOPMENT 262 788 2.15e-38 1.429e-35
7 CIRCULATORY SYSTEM DEVELOPMENT 262 788 2.15e-38 1.429e-35
8 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 313 1021 5.62e-38 3.269e-35
9 REGULATION OF CELLULAR COMPONENT MOVEMENT 256 771 2.114e-37 1.093e-34
10 CELL DEVELOPMENT 395 1426 9.229e-37 4.294e-34
11 RESPONSE TO ENDOGENOUS STIMULUS 398 1450 4.445e-36 1.88e-33
12 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 332 1142 3.543e-35 1.374e-32
13 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 473 1848 9.419e-35 3.371e-32
14 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 383 1395 1.067e-34 3.547e-32
15 REGULATION OF CELL DEVELOPMENT 264 836 2.231e-34 6.922e-32
16 TISSUE DEVELOPMENT 406 1518 4.49e-34 1.306e-31
17 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 299 1008 2.325e-33 6.365e-31
18 VASCULATURE DEVELOPMENT 173 469 1.242e-31 3.212e-29
19 POSITIVE REGULATION OF MOLECULAR FUNCTION 452 1791 1.367e-31 3.349e-29
20 REGULATION OF CELL PROLIFERATION 394 1496 1.727e-31 4.017e-29
21 POSITIVE REGULATION OF RESPONSE TO STIMULUS 476 1929 7.67e-31 1.7e-28
22 NEGATIVE REGULATION OF CELL COMMUNICATION 328 1192 8.175e-30 1.729e-27
23 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 361 1360 1.684e-29 3.407e-27
24 REGULATION OF PHOSPHORUS METABOLIC PROCESS 410 1618 6.187e-29 1.2e-26
25 POSITIVE REGULATION OF CELL COMMUNICATION 392 1532 1.539e-28 2.864e-26
26 POSITIVE REGULATION OF CELL DIFFERENTIATION 246 823 5.158e-28 9.231e-26
27 INTRACELLULAR SIGNAL TRANSDUCTION 397 1572 1.133e-27 1.953e-25
28 LOCOMOTION 304 1114 5.824e-27 9.678e-25
29 RESPONSE TO OXYGEN CONTAINING COMPOUND 357 1381 7.958e-27 1.277e-24
30 BLOOD VESSEL MORPHOGENESIS 138 364 8.505e-27 1.319e-24
31 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 227 750 1.028e-26 1.542e-24
32 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 237 799 1.75e-26 2.468e-24
33 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 335 1275 1.711e-26 2.468e-24
34 REGULATION OF NEURON DIFFERENTIATION 182 554 4.015e-26 5.407e-24
35 NEURON DIFFERENTIATION 252 874 4.067e-26 5.407e-24
36 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 273 983 1.73e-25 2.236e-23
37 REGULATION OF PROTEIN MODIFICATION PROCESS 414 1710 6.899e-25 8.676e-23
38 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 208 689 2.223e-24 2.722e-22
39 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 231 801 5.327e-24 6.356e-22
40 MUSCLE STRUCTURE DEVELOPMENT 149 432 6.248e-24 7.268e-22
41 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 166 513 4.051e-23 4.597e-21
42 CENTRAL NERVOUS SYSTEM DEVELOPMENT 243 872 5.848e-23 6.479e-21
43 POSITIVE REGULATION OF CATALYTIC ACTIVITY 370 1518 9.468e-23 1.001e-20
44 ORGAN MORPHOGENESIS 236 841 9.389e-23 1.001e-20
45 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 274 1036 3.791e-22 3.834e-20
46 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 274 1036 3.791e-22 3.834e-20
47 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 258 957 4.005e-22 3.965e-20
48 HEART DEVELOPMENT 153 466 4.3e-22 4.169e-20
49 REGULATION OF CELL MORPHOGENESIS 172 552 6.303e-22 5.985e-20
50 SKELETAL SYSTEM DEVELOPMENT 150 455 7.08e-22 6.589e-20
51 REGULATION OF MAPK CASCADE 194 660 2.577e-21 2.351e-19
52 REGULATION OF CELL PROJECTION ORGANIZATION 171 558 5.853e-21 5.237e-19
53 REGULATION OF HYDROLASE ACTIVITY 327 1327 6.617e-21 5.81e-19
54 RESPONSE TO GROWTH FACTOR 152 475 9.805e-21 8.448e-19
55 CELL MOTILITY 229 835 1.019e-20 8.471e-19
56 LOCALIZATION OF CELL 229 835 1.019e-20 8.471e-19
57 ANGIOGENESIS 109 293 1.113e-20 9.083e-19
58 NEURON DEVELOPMENT 198 687 1.188e-20 9.53e-19
59 CELLULAR COMPONENT MORPHOGENESIS 242 900 1.247e-20 9.83e-19
60 POSITIVE REGULATION OF LOCOMOTION 139 420 1.573e-20 1.22e-18
61 REGULATION OF TRANSPORT 415 1804 1.847e-20 1.409e-18
62 REGULATION OF NEURON PROJECTION DEVELOPMENT 136 408 2.003e-20 1.503e-18
63 HEAD DEVELOPMENT 202 709 2.048e-20 1.513e-18
64 EXTRACELLULAR STRUCTURE ORGANIZATION 111 304 2.658e-20 1.932e-18
65 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 236 876 2.983e-20 2.135e-18
66 RESPONSE TO WOUNDING 170 563 4.15e-20 2.926e-18
67 RESPONSE TO NITROGEN COMPOUND 232 859 4.549e-20 3.068e-18
68 REGULATION OF KINASE ACTIVITY 215 776 4.513e-20 3.068e-18
69 NEURON PROJECTION DEVELOPMENT 166 545 4.428e-20 3.068e-18
70 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 165 541 4.974e-20 3.26e-18
71 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 165 541 4.974e-20 3.26e-18
72 REGULATION OF GTPASE ACTIVITY 193 673 6.855e-20 4.43e-18
73 REGULATION OF SYSTEM PROCESS 157 507 8.106e-20 5.167e-18
74 POSITIVE REGULATION OF GENE EXPRESSION 399 1733 9.937e-20 6.248e-18
75 BEHAVIOR 158 516 2.067e-19 1.283e-17
76 REGULATION OF CELL DEATH 349 1472 2.275e-19 1.393e-17
77 POSITIVE REGULATION OF CELL DEVELOPMENT 148 472 2.656e-19 1.605e-17
78 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 406 1784 3.877e-19 2.313e-17
79 POSITIVE REGULATION OF HYDROLASE ACTIVITY 238 905 5.466e-19 3.219e-17
80 CELL ACTIVATION 168 568 6.85e-19 3.984e-17
81 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 116 337 8.006e-19 4.599e-17
82 RESPONSE TO HORMONE 235 893 8.491e-19 4.818e-17
83 CELLULAR RESPONSE TO NITROGEN COMPOUND 154 505 9.174e-19 5.143e-17
84 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 350 1492 1.2e-18 6.647e-17
85 POSITIVE REGULATION OF MAPK CASCADE 145 470 3.123e-18 1.71e-16
86 RESPONSE TO LIPID 232 888 3.687e-18 1.995e-16
87 NEGATIVE REGULATION OF PHOSPHORYLATION 134 422 4.195e-18 2.244e-16
88 TUBE DEVELOPMENT 161 552 1.608e-17 8.505e-16
89 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 278 1135 1.822e-17 9.525e-16
90 NEGATIVE REGULATION OF CELL PROLIFERATION 180 643 1.876e-17 9.697e-16
91 CONNECTIVE TISSUE DEVELOPMENT 78 194 1.991e-17 1.018e-15
92 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 99 278 2.15e-17 1.087e-15
93 RESPONSE TO ABIOTIC STIMULUS 256 1024 2.601e-17 1.301e-15
94 CELL CELL ADHESION 172 608 3.305e-17 1.636e-15
95 POSITIVE REGULATION OF CELL PROLIFERATION 214 814 3.815e-17 1.868e-15
96 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 135 437 4.105e-17 1.99e-15
97 CELL PROJECTION ORGANIZATION 231 902 5.5e-17 2.638e-15
98 REGULATION OF ION TRANSPORT 168 592 5.647e-17 2.681e-15
99 PROTEIN PHOSPHORYLATION 239 944 6.609e-17 3.106e-15
100 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 279 1152 7.699e-17 3.569e-15
101 RESPONSE TO EXTERNAL STIMULUS 403 1821 7.747e-17 3.569e-15
102 MUSCLE ORGAN DEVELOPMENT 97 277 1.62e-16 7.389e-15
103 TISSUE MORPHOGENESIS 154 533 2.077e-16 9.381e-15
104 RESPONSE TO ORGANIC CYCLIC COMPOUND 232 917 2.126e-16 9.511e-15
105 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 398 1805 2.327e-16 1.031e-14
106 WOUND HEALING 140 470 3.206e-16 1.408e-14
107 SINGLE ORGANISM BEHAVIOR 121 384 3.445e-16 1.498e-14
108 NEGATIVE REGULATION OF CELL DIFFERENTIATION 169 609 4.557e-16 1.964e-14
109 EPITHELIUM DEVELOPMENT 236 945 5.745e-16 2.452e-14
110 ACTIN FILAMENT BASED PROCESS 135 450 5.836e-16 2.469e-14
111 REGULATION OF METAL ION TRANSPORT 107 325 6.36e-16 2.666e-14
112 REGULATION OF BLOOD CIRCULATION 100 295 6.576e-16 2.732e-14
113 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 132 437 6.804e-16 2.802e-14
114 REGULATION OF VASCULATURE DEVELOPMENT 85 233 7.701e-16 3.143e-14
115 REGULATION OF CELL ADHESION 172 629 1.117e-15 4.52e-14
116 CELLULAR RESPONSE TO HORMONE STIMULUS 156 552 1.131e-15 4.537e-14
117 REGULATION OF GROWTH 172 633 2.118e-15 8.424e-14
118 NEURON PROJECTION MORPHOGENESIS 123 402 2.333e-15 9.199e-14
119 CIRCULATORY SYSTEM PROCESS 115 366 2.361e-15 9.232e-14
120 REGULATION OF TRANSFERASE ACTIVITY 234 946 2.447e-15 9.488e-14
121 POSITIVE REGULATION OF NEURON DIFFERENTIATION 101 306 3.457e-15 1.329e-13
122 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 82 229 8.418e-15 3.21e-13
123 TAXIS 135 464 8.499e-15 3.215e-13
124 POSITIVE REGULATION OF TRANSPORT 230 936 9.352e-15 3.509e-13
125 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 114 368 9.513e-15 3.541e-13
126 MUSCLE SYSTEM PROCESS 94 282 1.585e-14 5.854e-13
127 POSITIVE REGULATION OF KINASE ACTIVITY 138 482 1.721e-14 6.306e-13
128 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 242 1004 1.819e-14 6.611e-13
129 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 141 498 2.351e-14 8.481e-13
130 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 190 740 2.888e-14 1.034e-12
131 RESPONSE TO OXYGEN LEVELS 100 311 3.12e-14 1.108e-12
132 EMBRYO DEVELOPMENT 220 894 3.154e-14 1.112e-12
133 REGULATION OF MEMBRANE POTENTIAL 107 343 3.786e-14 1.324e-12
134 SINGLE ORGANISM CELL ADHESION 132 459 4.472e-14 1.553e-12
135 MUSCLE TISSUE DEVELOPMENT 91 275 6.777e-14 2.336e-12
136 BONE DEVELOPMENT 62 156 7.136e-14 2.442e-12
137 REGULATION OF HEART CONTRACTION 78 221 9.176e-14 3.116e-12
138 FOREBRAIN DEVELOPMENT 109 357 1.073e-13 3.619e-12
139 CARTILAGE DEVELOPMENT 59 147 1.718e-13 5.75e-12
140 MUSCLE CELL DIFFERENTIATION 81 237 2.276e-13 7.564e-12
141 REGULATION OF DEVELOPMENTAL GROWTH 93 289 2.344e-13 7.737e-12
142 REGULATION OF CELLULAR COMPONENT BIOGENESIS 192 767 2.765e-13 9.06e-12
143 IMMUNE SYSTEM PROCESS 415 1984 3.058e-13 9.949e-12
144 REGULATION OF CELL SUBSTRATE ADHESION 65 173 3.965e-13 1.281e-11
145 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 56 138 4.091e-13 1.313e-11
146 STEM CELL DIFFERENTIATION 69 190 5.118e-13 1.631e-11
147 SENSORY ORGAN DEVELOPMENT 136 493 5.799e-13 1.835e-11
148 IMMUNE SYSTEM DEVELOPMENT 154 582 6.73e-13 2.116e-11
149 NEGATIVE REGULATION OF LOCOMOTION 86 263 6.923e-13 2.162e-11
150 EMBRYONIC MORPHOGENESIS 145 539 8.238e-13 2.555e-11
151 CELLULAR RESPONSE TO LIPID 128 457 8.739e-13 2.693e-11
152 GROWTH 118 410 9.494e-13 2.906e-11
153 CELL CELL SIGNALING 190 767 1.029e-12 3.131e-11
154 NEGATIVE REGULATION OF CELL DEATH 210 872 1.193e-12 3.606e-11
155 DEVELOPMENTAL GROWTH 101 333 1.347e-12 4.043e-11
156 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 130 470 1.542e-12 4.598e-11
157 MESENCHYME DEVELOPMENT 68 190 1.66e-12 4.921e-11
158 REGULATION OF EPITHELIAL CELL MIGRATION 62 166 1.861e-12 5.481e-11
159 REGULATION OF EPITHELIAL CELL PROLIFERATION 90 285 1.88e-12 5.502e-11
160 LEUKOCYTE ACTIVATION 118 414 1.938e-12 5.635e-11
161 UROGENITAL SYSTEM DEVELOPMENT 93 299 2.134e-12 6.168e-11
162 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 159 616 2.49e-12 7.15e-11
163 TUBE MORPHOGENESIS 98 323 2.835e-12 8.093e-11
164 NEGATIVE REGULATION OF GENE EXPRESSION 323 1493 2.901e-12 8.231e-11
165 REGULATION OF RESPONSE TO STRESS 318 1468 3.712e-12 1.047e-10
166 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 218 926 4.614e-12 1.293e-10
167 PHOSPHORYLATION 274 1228 4.772e-12 1.33e-10
168 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 93 303 4.947e-12 1.37e-10
169 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 71 207 5.593e-12 1.54e-10
170 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 407 1977 5.899e-12 1.615e-10
171 REGULATION OF RESPONSE TO WOUNDING 116 413 8.479e-12 2.307e-10
172 REGULATION OF HOMEOSTATIC PROCESS 123 447 9.02e-12 2.44e-10
173 MORPHOGENESIS OF AN EPITHELIUM 113 400 1.06e-11 2.85e-10
174 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 76 232 1.349e-11 3.607e-10
175 SYNAPSE ORGANIZATION 55 145 1.612e-11 4.287e-10
176 POSITIVE REGULATION OF CELL DEATH 154 605 1.753e-11 4.634e-10
177 REGULATION OF MAP KINASE ACTIVITY 95 319 1.959e-11 5.151e-10
178 REGULATION OF BODY FLUID LEVELS 134 506 2.032e-11 5.313e-10
179 MESENCHYMAL CELL DIFFERENTIATION 52 134 2.103e-11 5.436e-10
180 REGULATION OF CELLULAR LOCALIZATION 280 1277 2.101e-11 5.436e-10
181 REGULATION OF CALCIUM ION TRANSPORT 70 209 2.746e-11 7.058e-10
182 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 64 184 3.089e-11 7.897e-10
183 NEGATIVE REGULATION OF CELL DEVELOPMENT 91 303 3.131e-11 7.961e-10
184 POSITIVE REGULATION OF ION TRANSPORT 76 236 3.427e-11 8.667e-10
185 SECOND MESSENGER MEDIATED SIGNALING 58 160 3.901e-11 9.812e-10
186 REGULATION OF TRANSPORTER ACTIVITY 67 198 4.348e-11 1.088e-09
187 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 65 190 4.943e-11 1.23e-09
188 REGULATION OF MUSCLE SYSTEM PROCESS 66 195 5.99e-11 1.482e-09
189 REGULATION OF TRANSMEMBRANE TRANSPORT 116 426 7.205e-11 1.774e-09
190 REGULATION OF ACTIN FILAMENT BASED PROCESS 92 312 7.331e-11 1.795e-09
191 MORPHOGENESIS OF A BRANCHING STRUCTURE 59 167 8.816e-11 2.148e-09
192 RESPONSE TO STEROID HORMONE 130 497 9.937e-11 2.396e-09
193 RESPIRATORY SYSTEM DEVELOPMENT 66 197 9.892e-11 2.396e-09
194 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 74 232 1.022e-10 2.451e-09
195 LYMPHOCYTE ACTIVATION 98 342 1.048e-10 2.501e-09
196 CYTOSKELETON ORGANIZATION 196 838 1.058e-10 2.511e-09
197 NEGATIVE REGULATION OF TRANSPORT 122 458 1.085e-10 2.563e-09
198 TELENCEPHALON DEVELOPMENT 73 228 1.123e-10 2.638e-09
199 COGNITION 78 251 1.32e-10 3.087e-09
200 LEUKOCYTE DIFFERENTIATION 87 292 1.332e-10 3.099e-09
201 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 319 1517 1.35e-10 3.125e-09
202 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 53 144 1.395e-10 3.214e-09
203 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 123 465 1.478e-10 3.388e-09
204 HEART MORPHOGENESIS 69 212 1.607e-10 3.665e-09
205 CHEMICAL HOMEOSTASIS 202 874 1.623e-10 3.683e-09
206 CELL PART MORPHOGENESIS 156 633 1.755e-10 3.945e-09
207 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 68 208 1.749e-10 3.945e-09
208 REGULATION OF OSSIFICATION 61 178 1.776e-10 3.974e-09
209 HOMEOSTATIC PROCESS 286 1337 2.104e-10 4.685e-09
210 RESPONSE TO PEPTIDE 110 404 2.244e-10 4.972e-09
211 CELLULAR RESPONSE TO ACID CHEMICAL 60 175 2.446e-10 5.394e-09
212 NEGATIVE REGULATION OF GROWTH 74 236 2.47e-10 5.422e-09
213 REGULATION OF ION HOMEOSTASIS 66 201 2.618e-10 5.719e-09
214 EMBRYONIC ORGAN DEVELOPMENT 110 406 3.077e-10 6.689e-09
215 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 240 1087 3.226e-10 6.981e-09
216 HEMOSTASIS 90 311 3.452e-10 7.436e-09
217 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 79 262 5.003e-10 1.073e-08
218 RESPONSE TO INORGANIC SUBSTANCE 124 479 5.438e-10 1.161e-08
219 NEGATIVE REGULATION OF KINASE ACTIVITY 76 250 7.023e-10 1.492e-08
220 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 30 62 7.074e-10 1.496e-08
221 FAT CELL DIFFERENTIATION 42 106 8.187e-10 1.724e-08
222 PLATELET ACTIVATION 51 142 8.412e-10 1.763e-08
223 NEURON MIGRATION 43 110 8.535e-10 1.781e-08
224 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 150 616 9.71e-10 2.017e-08
225 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 41 103 1.1e-09 2.275e-08
226 REGULATION OF CARTILAGE DEVELOPMENT 30 63 1.155e-09 2.378e-08
227 STRIATED MUSCLE CELL DIFFERENTIATION 58 173 1.284e-09 2.631e-08
228 REGULATION OF CELL GROWTH 105 391 1.328e-09 2.71e-08
229 REGULATION OF PROTEIN LOCALIZATION 212 950 1.439e-09 2.924e-08
230 RESPONSE TO CYTOKINE 168 714 1.494e-09 3.022e-08
231 CARDIAC MUSCLE TISSUE DEVELOPMENT 50 140 1.533e-09 3.087e-08
232 NEGATIVE REGULATION OF MOLECULAR FUNCTION 235 1079 1.848e-09 3.707e-08
233 CELLULAR RESPONSE TO PEPTIDE 80 274 2.074e-09 4.141e-08
234 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 107 404 2.143e-09 4.261e-08
235 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 48 133 2.17e-09 4.297e-08
236 MUSCLE CONTRACTION 71 233 2.257e-09 4.449e-08
237 REGULATION OF SECRETION 164 699 2.923e-09 5.739e-08
238 CELL SUBSTRATE ADHESION 55 164 3.357e-09 6.563e-08
239 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 52 152 4.098e-09 7.978e-08
240 CELL DEATH 219 1001 4.562e-09 8.844e-08
241 ACTIVATION OF PROTEIN KINASE ACTIVITY 80 279 5.159e-09 9.961e-08
242 OSSIFICATION 74 251 5.193e-09 9.985e-08
243 SKELETAL SYSTEM MORPHOGENESIS 63 201 5.286e-09 1.012e-07
244 CARDIOCYTE DIFFERENTIATION 38 96 5.326e-09 1.016e-07
245 REGULATION OF ORGAN MORPHOGENESIS 72 242 5.44e-09 1.033e-07
246 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 39 100 5.541e-09 1.048e-07
247 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 40 104 5.691e-09 1.072e-07
248 RESPONSE TO ALCOHOL 97 362 6.321e-09 1.186e-07
249 REGULATION OF ANATOMICAL STRUCTURE SIZE 119 472 6.46e-09 1.207e-07
250 MODULATION OF SYNAPTIC TRANSMISSION 84 301 8.685e-09 1.616e-07
251 REGULATION OF PHOSPHOLIPASE ACTIVITY 29 64 9.116e-09 1.69e-07
252 ENDOTHELIUM DEVELOPMENT 36 90 9.614e-09 1.775e-07
253 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 88 321 9.837e-09 1.809e-07
254 EYE DEVELOPMENT 89 326 1.009e-08 1.848e-07
255 REGULATION OF CELL JUNCTION ASSEMBLY 30 68 1.098e-08 2.003e-07
256 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 60 191 1.104e-08 2.007e-07
257 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 52 156 1.125e-08 2.037e-07
258 LEARNING 46 131 1.256e-08 2.266e-07
259 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 94 352 1.295e-08 2.327e-07
260 RESPONSE TO MECHANICAL STIMULUS 64 210 1.361e-08 2.435e-07
261 CARDIAC CHAMBER DEVELOPMENT 49 144 1.386e-08 2.471e-07
262 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 53 162 1.684e-08 2.991e-07
263 REGULATION OF CHEMOTAXIS 57 180 1.851e-08 3.274e-07
264 REGULATION OF INTRACELLULAR TRANSPORT 146 621 1.896e-08 3.341e-07
265 REGULATION OF CYTOPLASMIC TRANSPORT 119 481 2.05e-08 3.599e-07
266 DEVELOPMENTAL CELL GROWTH 32 77 2.115e-08 3.7e-07
267 REGULATION OF IMMUNE SYSTEM PROCESS 287 1403 2.165e-08 3.773e-07
268 LEUKOCYTE MIGRATION 74 259 2.255e-08 3.916e-07
269 LOCOMOTORY BEHAVIOR 57 181 2.306e-08 3.989e-07
270 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 43 121 2.478e-08 4.27e-07
271 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 30 70 2.487e-08 4.27e-07
272 REGULATION OF RECEPTOR ACTIVITY 42 117 2.566e-08 4.39e-07
273 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 77 274 2.58e-08 4.397e-07
274 RHYTHMIC PROCESS 82 298 2.59e-08 4.399e-07
275 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 26 56 2.845e-08 4.814e-07
276 CALCIUM ION TRANSPORT 66 223 2.906e-08 4.899e-07
277 REGULATION OF BLOOD PRESSURE 54 169 3.083e-08 5.178e-07
278 REGULATION OF CHONDROCYTE DIFFERENTIATION 23 46 3.121e-08 5.213e-07
279 NEURON PROJECTION GUIDANCE 62 205 3.126e-08 5.213e-07
280 SYSTEM PROCESS 352 1785 3.228e-08 5.365e-07
281 RESPONSE TO ACID CHEMICAL 86 319 3.332e-08 5.518e-07
282 REGULATION OF MUSCLE CELL DIFFERENTIATION 50 152 3.472e-08 5.729e-07
283 CALCIUM MEDIATED SIGNALING 35 90 3.606e-08 5.928e-07
284 CELL GROWTH 46 135 3.625e-08 5.94e-07
285 REGULATION OF PROTEIN SECRETION 100 389 3.675e-08 6e-07
286 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 60 197 3.912e-08 6.364e-07
287 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 53 166 4.243e-08 6.879e-07
288 PALLIUM DEVELOPMENT 50 153 4.405e-08 7.099e-07
289 BONE MORPHOGENESIS 32 79 4.409e-08 7.099e-07
290 ION HOMEOSTASIS 136 576 4.437e-08 7.119e-07
291 DIVALENT INORGANIC CATION TRANSPORT 75 268 4.71e-08 7.531e-07
292 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 103 406 4.75e-08 7.569e-07
293 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 37 99 5.09e-08 8.083e-07
294 REGULATION OF BINDING 78 283 5.209e-08 8.244e-07
295 MEMBRANE DEPOLARIZATION 27 61 5.422e-08 8.553e-07
296 AMEBOIDAL TYPE CELL MIGRATION 50 154 5.571e-08 8.757e-07
297 REGULATION OF CELLULAR RESPONSE TO STRESS 157 691 6.145e-08 9.626e-07
298 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 28 65 6.32e-08 9.868e-07
299 DIVALENT INORGANIC CATION HOMEOSTASIS 90 343 6.37e-08 9.913e-07
300 PEPTIDYL TYROSINE MODIFICATION 57 186 6.683e-08 1.037e-06
301 CARDIAC CHAMBER MORPHOGENESIS 38 104 6.8e-08 1.051e-06
302 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 37 100 6.906e-08 1.064e-06
303 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 131 554 7.158e-08 1.099e-06
304 REGULATION OF ERK1 AND ERK2 CASCADE 68 238 8.25e-08 1.263e-06
305 ION TRANSPORT 259 1262 8.32e-08 1.269e-06
306 REGULATION OF MUSCLE CONTRACTION 48 147 8.365e-08 1.272e-06
307 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 155 684 8.91e-08 1.35e-06
308 POSITIVE REGULATION OF CELL ADHESION 96 376 9.724e-08 1.469e-06
309 SENSORY ORGAN MORPHOGENESIS 68 239 9.843e-08 1.482e-06
310 NEGATIVE REGULATION OF CELL GROWTH 53 170 1.022e-07 1.535e-06
311 REGULATION OF ENDOTHELIAL CELL MIGRATION 40 114 1.12e-07 1.675e-06
312 CARDIAC MUSCLE CELL DIFFERENTIATION 30 74 1.129e-07 1.684e-06
313 REPRODUCTIVE SYSTEM DEVELOPMENT 102 408 1.201e-07 1.785e-06
314 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 37 102 1.25e-07 1.852e-06
315 PLASMA MEMBRANE ORGANIZATION 60 203 1.28e-07 1.885e-06
316 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 36 98 1.276e-07 1.885e-06
317 ACTION POTENTIAL 35 94 1.291e-07 1.895e-06
318 MULTICELLULAR ORGANISMAL SIGNALING 42 123 1.308e-07 1.908e-06
319 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 139 602 1.306e-07 1.908e-06
320 REGULATION OF INFLAMMATORY RESPONSE 79 294 1.38e-07 2.007e-06
321 GLOMERULUS DEVELOPMENT 23 49 1.39e-07 2.015e-06
322 RESPONSE TO CORTICOSTEROID 54 176 1.402e-07 2.026e-06
323 MULTI MULTICELLULAR ORGANISM PROCESS 62 213 1.462e-07 2.106e-06
324 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 26 60 1.607e-07 2.307e-06
325 LYMPHOCYTE DIFFERENTIATION 61 209 1.654e-07 2.368e-06
326 REGULATION OF JNK CASCADE 50 159 1.723e-07 2.459e-06
327 REGULATION OF AXONOGENESIS 52 168 1.738e-07 2.473e-06
328 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 24 53 1.744e-07 2.474e-06
329 POSITIVE REGULATION OF HEART GROWTH 16 27 1.846e-07 2.61e-06
330 REGULATED EXOCYTOSIS 64 224 1.959e-07 2.762e-06
331 ORGAN GROWTH 28 68 2.009e-07 2.825e-06
332 REGULATION OF OSTEOBLAST DIFFERENTIATION 39 112 2.022e-07 2.833e-06
333 KIDNEY EPITHELIUM DEVELOPMENT 42 125 2.176e-07 3.04e-06
334 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 31 80 2.354e-07 3.279e-06
335 SECRETION BY CELL 116 486 2.381e-07 3.308e-06
336 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 32 84 2.398e-07 3.32e-06
337 AGING 72 264 2.616e-07 3.612e-06
338 REGULATION OF STEM CELL DIFFERENTIATION 39 113 2.639e-07 3.633e-06
339 DIGESTIVE SYSTEM DEVELOPMENT 47 148 2.886e-07 3.962e-06
340 CEREBRAL CORTEX DEVELOPMENT 37 105 2.921e-07 3.998e-06
341 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 46 144 3.175e-07 4.333e-06
342 CELL CHEMOTAXIS 50 162 3.277e-07 4.458e-06
343 CELLULAR HOMEOSTASIS 151 676 3.3e-07 4.477e-06
344 POSITIVE REGULATION OF ENDOCYTOSIS 39 114 3.429e-07 4.624e-06
345 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 61 213 3.429e-07 4.624e-06
346 REGULATION OF CATABOLIC PROCESS 161 731 3.444e-07 4.632e-06
347 FOREBRAIN CELL MIGRATION 26 62 3.535e-07 4.74e-06
348 EPITHELIAL CELL DIFFERENTIATION 117 495 3.628e-07 4.851e-06
349 MUSCLE HYPERTROPHY 16 28 3.699e-07 4.931e-06
350 CELL CYCLE ARREST 48 154 4.045e-07 5.377e-06
351 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 24 55 4.086e-07 5.416e-06
352 REGULATION OF CELL MATRIX ADHESION 33 90 4.423e-07 5.846e-06
353 NEPHRON DEVELOPMENT 39 115 4.435e-07 5.846e-06
354 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 32 86 4.481e-07 5.89e-06
355 MUSCLE CELL DEVELOPMENT 42 128 4.53e-07 5.937e-06
356 VASCULOGENESIS 25 59 4.663e-07 6.095e-06
357 SECRETION 134 588 4.774e-07 6.222e-06
358 COLLAGEN FIBRIL ORGANIZATION 19 38 4.95e-07 6.434e-06
359 REGULATION OF MUSCLE TISSUE DEVELOPMENT 36 103 5.287e-07 6.833e-06
360 REGULATION OF MUSCLE ORGAN DEVELOPMENT 36 103 5.287e-07 6.833e-06
361 APPENDAGE DEVELOPMENT 51 169 5.43e-07 6.979e-06
362 LIMB DEVELOPMENT 51 169 5.43e-07 6.979e-06
363 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 27 67 5.546e-07 7.109e-06
364 VESICLE MEDIATED TRANSPORT 250 1239 5.982e-07 7.647e-06
365 REGULATION OF LIPASE ACTIVITY 31 83 6.128e-07 7.812e-06
366 LEUKOCYTE CELL CELL ADHESION 69 255 6.315e-07 8.028e-06
367 CELLULAR CHEMICAL HOMEOSTASIS 130 570 6.75e-07 8.558e-06
368 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 22 49 6.789e-07 8.56e-06
369 REGULATION OF HEART GROWTH 20 42 6.789e-07 8.56e-06
370 CELLULAR RESPONSE TO OXYGEN LEVELS 45 143 6.821e-07 8.578e-06
371 CHONDROCYTE DIFFERENTIATION 25 60 6.847e-07 8.587e-06
372 REGULATION OF WNT SIGNALING PATHWAY 80 310 6.976e-07 8.726e-06
373 REGULATION OF SYNAPSE ORGANIZATION 38 113 7.881e-07 9.832e-06
374 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 41 126 7.917e-07 9.85e-06
375 REGULATION OF CATION CHANNEL ACTIVITY 32 88 8.152e-07 1.011e-05
376 REGULATION OF PHOSPHOLIPASE C ACTIVITY 19 39 8.28e-07 1.022e-05
377 NEGATIVE CHEMOTAXIS 19 39 8.28e-07 1.022e-05
378 POSITIVE REGULATION OF OSSIFICATION 31 84 8.311e-07 1.023e-05
379 REGULATION OF CALCIUM MEDIATED SIGNALING 29 76 8.337e-07 1.024e-05
380 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 59 209 8.953e-07 1.096e-05
381 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 42 131 9.119e-07 1.114e-05
382 EAR DEVELOPMENT 56 195 9.249e-07 1.127e-05
383 GLAND MORPHOGENESIS 34 97 1.004e-06 1.22e-05
384 RESPONSE TO METAL ION 84 333 1.027e-06 1.242e-05
385 CELL PROLIFERATION 148 672 1.026e-06 1.242e-05
386 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 47 154 1.043e-06 1.257e-05
387 SYNAPSE ASSEMBLY 27 69 1.108e-06 1.332e-05
388 REGULATION OF ORGAN GROWTH 28 73 1.135e-06 1.361e-05
389 ACTOMYOSIN STRUCTURE ORGANIZATION 29 77 1.145e-06 1.369e-05
390 REGULATION OF FAT CELL DIFFERENTIATION 36 106 1.165e-06 1.39e-05
391 METAL ION TRANSPORT 131 582 1.29e-06 1.535e-05
392 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 16 30 1.304e-06 1.548e-05
393 ACTIN FILAMENT ORGANIZATION 51 174 1.434e-06 1.698e-05
394 REGULATION OF CARDIAC MUSCLE CONTRACTION 26 66 1.499e-06 1.77e-05
395 REGULATION OF DENDRITE DEVELOPMENT 39 120 1.506e-06 1.775e-05
396 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 27 70 1.544e-06 1.814e-05
397 CELLULAR RESPONSE TO CYTOKINE STIMULUS 135 606 1.607e-06 1.883e-05
398 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 38 116 1.641e-06 1.914e-05
399 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 57 203 1.639e-06 1.914e-05
400 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 34 99 1.713e-06 1.983e-05
401 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 34 99 1.713e-06 1.983e-05
402 MYELOID CELL DIFFERENTIATION 54 189 1.705e-06 1.983e-05
403 REGULATION OF VESICLE MEDIATED TRANSPORT 108 462 1.758e-06 2.03e-05
404 CATION TRANSPORT 169 796 1.998e-06 2.298e-05
405 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 11 16 2.001e-06 2.298e-05
406 DIGESTIVE TRACT MORPHOGENESIS 21 48 2.042e-06 2.34e-05
407 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 38 117 2.079e-06 2.376e-05
408 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 26 67 2.098e-06 2.393e-05
409 ARTERY DEVELOPMENT 28 75 2.136e-06 2.43e-05
410 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 46 153 2.143e-06 2.431e-05
411 LUNG ALVEOLUS DEVELOPMENT 19 41 2.164e-06 2.449e-05
412 REGULATION OF WOUND HEALING 40 126 2.17e-06 2.451e-05
413 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 42 135 2.206e-06 2.485e-05
414 NEGATIVE REGULATION OF SECRETION 56 200 2.216e-06 2.491e-05
415 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 89 365 2.305e-06 2.585e-05
416 RESPONSE TO PURINE CONTAINING COMPOUND 47 158 2.32e-06 2.595e-05
417 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 41 131 2.447e-06 2.73e-05
418 EMBRYONIC ORGAN MORPHOGENESIS 72 279 2.46e-06 2.732e-05
419 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 36 109 2.46e-06 2.732e-05
420 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 32 92 2.503e-06 2.773e-05
421 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 60 220 2.51e-06 2.774e-05
422 EPITHELIAL TO MESENCHYMAL TRANSITION 23 56 2.558e-06 2.814e-05
423 OUTFLOW TRACT MORPHOGENESIS 23 56 2.558e-06 2.814e-05
424 SPROUTING ANGIOGENESIS 20 45 2.642e-06 2.893e-05
425 SMOOTH MUSCLE CONTRACTION 20 45 2.642e-06 2.893e-05
426 NEGATIVE REGULATION OF MAPK CASCADE 44 145 2.692e-06 2.941e-05
427 POSITIVE REGULATION OF ORGAN GROWTH 18 38 2.699e-06 2.941e-05
428 POSITIVE REGULATION OF BINDING 40 127 2.708e-06 2.944e-05
429 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 24 60 2.732e-06 2.956e-05
430 EXOCYTOSIS 78 310 2.727e-06 2.956e-05
431 SYNAPTIC SIGNALING 100 424 2.78e-06 3.001e-05
432 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 90 372 2.866e-06 3.087e-05
433 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 28 76 2.895e-06 3.111e-05
434 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 63 236 3.107e-06 3.324e-05
435 IN UTERO EMBRYONIC DEVELOPMENT 78 311 3.108e-06 3.324e-05
436 REGULATION OF PROTEIN IMPORT 52 183 3.14e-06 3.351e-05
437 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 75 296 3.194e-06 3.401e-05
438 CYTOKINE MEDIATED SIGNALING PATHWAY 105 452 3.292e-06 3.491e-05
439 CELL MATRIX ADHESION 38 119 3.294e-06 3.491e-05
440 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 35 106 3.398e-06 3.591e-05
441 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 22 53 3.411e-06 3.591e-05
442 CELLULAR RESPONSE TO AMINO ACID STIMULUS 22 53 3.411e-06 3.591e-05
443 CELL FATE COMMITMENT 61 227 3.509e-06 3.685e-05
444 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 10 14 3.535e-06 3.704e-05
445 PROTEIN LOCALIZATION TO CELL PERIPHERY 45 151 3.572e-06 3.735e-05
446 RESPONSE TO CALCIUM ION 37 115 3.617e-06 3.773e-05
447 CYCLIC NUCLEOTIDE METABOLIC PROCESS 23 57 3.676e-06 3.809e-05
448 GLAND DEVELOPMENT 94 395 3.673e-06 3.809e-05
449 RENAL SYSTEM PROCESS 34 102 3.675e-06 3.809e-05
450 REGULATION OF LIPID METABOLIC PROCESS 72 282 3.72e-06 3.847e-05
451 INOSITOL LIPID MEDIATED SIGNALING 39 124 3.73e-06 3.849e-05
452 REGULATION OF CYTOSKELETON ORGANIZATION 114 502 4.004e-06 4.121e-05
453 HOMEOSTASIS OF NUMBER OF CELLS 50 175 4.059e-06 4.17e-05
454 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 18 39 4.303e-06 4.395e-05
455 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 39 4.303e-06 4.395e-05
456 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 56 204 4.307e-06 4.395e-05
457 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 21 50 4.53e-06 4.592e-05
458 REGULATION OF ADHERENS JUNCTION ORGANIZATION 21 50 4.53e-06 4.592e-05
459 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 173 829 4.528e-06 4.592e-05
460 REGULATION OF CELLULAR PROTEIN LOCALIZATION 123 552 4.561e-06 4.614e-05
461 REGULATION OF CYTOKINE PRODUCTION 125 563 4.614e-06 4.657e-05
462 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 15 29 4.649e-06 4.662e-05
463 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 29 4.649e-06 4.662e-05
464 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 15 29 4.649e-06 4.662e-05
465 REGULATION OF HEART RATE 30 86 4.769e-06 4.772e-05
466 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 73 289 4.835e-06 4.828e-05
467 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 11 17 4.887e-06 4.869e-05
468 CARDIAC CONDUCTION 29 82 5.003e-06 4.974e-05
469 LIPID PHOSPHORYLATION 33 99 5.078e-06 5.038e-05
470 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 24 62 5.395e-06 5.341e-05
471 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 32 95 5.467e-06 5.39e-05
472 POSITIVE REGULATION OF LIPASE ACTIVITY 25 66 5.467e-06 5.39e-05
473 INNERVATION 13 23 5.593e-06 5.502e-05
474 ADULT BEHAVIOR 41 135 5.673e-06 5.569e-05
475 RESPONSE TO OXIDATIVE STRESS 85 352 5.781e-06 5.663e-05
476 CELLULAR RESPONSE TO BIOTIC STIMULUS 47 163 5.943e-06 5.798e-05
477 VASCULAR PROCESS IN CIRCULATORY SYSTEM 47 163 5.943e-06 5.798e-05
478 REGULATION OF SYNAPTIC PLASTICITY 42 140 6.184e-06 6.02e-05
479 OVULATION CYCLE 36 113 6.265e-06 6.086e-05
480 NEGATIVE REGULATION OF CHEMOTAXIS 21 51 6.604e-06 6.402e-05
481 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 40 6.717e-06 6.497e-05
482 CALCIUM ION TRANSMEMBRANE TRANSPORT 46 159 6.741e-06 6.507e-05
483 EYE MORPHOGENESIS 41 136 6.944e-06 6.689e-05
484 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 27 75 7.168e-06 6.891e-05
485 T CELL DIFFERENTIATION 38 123 7.899e-06 7.578e-05
486 CELLULAR RESPONSE TO INSULIN STIMULUS 43 146 8.101e-06 7.756e-05
487 CELLULAR RESPONSE TO OXIDATIVE STRESS 51 184 8.418e-06 8.043e-05
488 SKELETAL MUSCLE ORGAN DEVELOPMENT 41 137 8.473e-06 8.079e-05
489 TISSUE MIGRATION 29 84 8.609e-06 8.192e-05
490 POSITIVE REGULATION OF GROWTH 62 238 8.653e-06 8.217e-05
491 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 20 48 8.807e-06 8.346e-05
492 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 10 15 9.153e-06 8.639e-05
493 REGULATION OF HEAT GENERATION 10 15 9.153e-06 8.639e-05
494 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 45 156 9.177e-06 8.644e-05
495 CARDIAC VENTRICLE DEVELOPMENT 34 106 9.509e-06 8.938e-05
496 MULTICELLULAR ORGANISM METABOLIC PROCESS 31 93 9.703e-06 9.103e-05
497 LIPID LOCALIZATION 67 264 9.851e-06 9.223e-05
498 ENDOTHELIAL CELL DIFFERENTIATION 26 72 9.875e-06 9.226e-05
499 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 13 24 1.051e-05 9.796e-05
500 REPRODUCTION 252 1297 1.062e-05 9.884e-05
501 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 16 34 1.077e-05 9.985e-05
502 CAMP METABOLIC PROCESS 16 34 1.077e-05 9.985e-05
503 RESPONSE TO INSULIN 55 205 1.089e-05 0.0001007
504 RAS PROTEIN SIGNAL TRANSDUCTION 42 143 1.107e-05 0.0001022
505 PALATE DEVELOPMENT 29 85 1.119e-05 0.0001031
506 EPITHELIAL CELL DEVELOPMENT 51 186 1.169e-05 0.0001075
507 PLATELET DEGRANULATION 34 107 1.193e-05 0.0001095
508 RESPONSE TO ORGANOPHOSPHORUS 41 139 1.25e-05 0.0001143
509 REGULATION OF CELL SHAPE 41 139 1.25e-05 0.0001143
510 REGULATION OF BMP SIGNALING PATHWAY 27 77 1.256e-05 0.0001144
511 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 48 172 1.255e-05 0.0001144
512 CARDIAC CELL DEVELOPMENT 20 49 1.277e-05 0.000116
513 ENDOCYTOSIS 113 509 1.308e-05 0.0001186
514 REGULATION OF CIRCADIAN RHYTHM 33 103 1.313e-05 0.0001189
515 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 17 38 1.331e-05 0.0001203
516 MESONEPHROS DEVELOPMENT 30 90 1.342e-05 0.000121
517 ENDOTHELIAL CELL MIGRATION 22 57 1.391e-05 0.0001252
518 POSITIVE REGULATION OF STEM CELL PROLIFERATION 23 61 1.403e-05 0.0001261
519 REGULATION OF PROTEIN BINDING 47 168 1.432e-05 0.0001284
520 REGULATION OF HORMONE SECRETION 66 262 1.48e-05 0.0001324
521 REGULATION OF HORMONE LEVELS 107 478 1.515e-05 0.0001353
522 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 37 122 1.644e-05 0.0001465
523 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 83 351 1.703e-05 0.0001514
524 RESPONSE TO MONOAMINE 16 35 1.705e-05 0.0001514
525 REGULATION OF ACUTE INFLAMMATORY RESPONSE 26 74 1.736e-05 0.0001538
526 NEGATIVE REGULATION OF CELL ADHESION 58 223 1.747e-05 0.0001546
527 RHO PROTEIN SIGNAL TRANSDUCTION 20 50 1.826e-05 0.0001612
528 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 66 1.875e-05 0.0001646
529 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 66 1.875e-05 0.0001646
530 REGULATION OF CARDIAC CONDUCTION 24 66 1.875e-05 0.0001646
531 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 13 25 1.884e-05 0.0001651
532 CELLULAR RESPONSE TO EXTERNAL STIMULUS 66 264 1.921e-05 0.000168
533 REGULATION OF ENDOCYTOSIS 53 199 1.947e-05 0.00017
534 REGULATION OF PEPTIDE SECRETION 55 209 1.988e-05 0.0001733
535 REGULATION OF POTASSIUM ION TRANSPORT 28 83 2e-05 0.000174
536 TRABECULA MORPHOGENESIS 17 39 2.027e-05 0.000176
537 NEURON CELL CELL ADHESION 10 16 2.107e-05 0.0001826
538 DENDRITE DEVELOPMENT 27 79 2.142e-05 0.0001849
539 REGULATION OF SYNAPSE ASSEMBLY 27 79 2.142e-05 0.0001849
540 ADIPOSE TISSUE DEVELOPMENT 15 32 2.156e-05 0.0001857
541 CELL JUNCTION ORGANIZATION 50 185 2.163e-05 0.000186
542 REGENERATION 45 161 2.212e-05 0.0001899
543 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 11 19 2.22e-05 0.0001899
544 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 11 19 2.22e-05 0.0001899
545 REGULATION OF CELL CYCLE 190 949 2.264e-05 0.0001933
546 REGULATION OF EXTENT OF CELL GROWTH 32 101 2.272e-05 0.0001933
547 POSITIVE REGULATION OF AUTOPHAGY 26 75 2.276e-05 0.0001933
548 NEURAL CREST CELL DIFFERENTIATION 26 75 2.276e-05 0.0001933
549 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 18 43 2.282e-05 0.0001934
550 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 34 110 2.294e-05 0.0001941
551 REGULATION OF COAGULATION 29 88 2.372e-05 0.0001996
552 OVULATION CYCLE PROCESS 29 88 2.372e-05 0.0001996
553 REGULATION OF STEM CELL PROLIFERATION 29 88 2.372e-05 0.0001996
554 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 31 97 2.505e-05 0.0002104
555 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 35 115 2.53e-05 0.0002121
556 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 28 84 2.57e-05 0.0002147
557 RESPONSE TO REACTIVE OXYGEN SPECIES 51 191 2.568e-05 0.0002147
558 NEURAL CREST CELL MIGRATION 20 51 2.578e-05 0.000215
559 POSITIVE REGULATION OF RESPONSE TO WOUNDING 45 162 2.618e-05 0.0002175
560 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 45 162 2.618e-05 0.0002175
561 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 41 143 2.627e-05 0.0002179
562 CELL JUNCTION ASSEMBLY 38 129 2.64e-05 0.0002186
563 CARDIAC MUSCLE CELL CONTRACTION 14 29 2.677e-05 0.0002212
564 ACTIN FILAMENT BASED MOVEMENT 30 93 2.753e-05 0.0002271
565 REGULATION OF CELL SIZE 47 172 2.778e-05 0.0002287
566 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 150 724 2.85e-05 0.0002343
567 REGULATION OF FEVER GENERATION 8 11 2.979e-05 0.000244
568 RESPONSE TO DRUG 97 431 2.975e-05 0.000244
569 POSITIVE REGULATION OF MAP KINASE ACTIVITY 54 207 3.06e-05 0.0002502
570 MEMORY 31 98 3.138e-05 0.0002551
571 REGULATION OF JAK STAT CASCADE 41 144 3.141e-05 0.0002551
572 MYELOID LEUKOCYTE ACTIVATION 31 98 3.138e-05 0.0002551
573 REGULATION OF STAT CASCADE 41 144 3.141e-05 0.0002551
574 REGULATION OF AMINE TRANSPORT 25 72 3.15e-05 0.0002553
575 REGULATION OF SEQUESTERING OF CALCIUM ION 33 107 3.16e-05 0.0002557
576 GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 13 26 3.245e-05 0.0002622
577 CARDIAC SEPTUM DEVELOPMENT 28 85 3.283e-05 0.0002648
578 APOPTOTIC SIGNALING PATHWAY 70 289 3.335e-05 0.0002685
579 RESPONSE TO BMP 30 94 3.462e-05 0.0002778
580 CELLULAR RESPONSE TO BMP STIMULUS 30 94 3.462e-05 0.0002778
581 DEVELOPMENTAL MATURATION 51 193 3.472e-05 0.000278
582 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 48 3.502e-05 0.0002795
583 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 19 48 3.502e-05 0.0002795
584 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 56 218 3.532e-05 0.0002814
585 METANEPHROS DEVELOPMENT 27 81 3.559e-05 0.0002826
586 REGULATION OF SMOOTH MUSCLE CONTRACTION 22 60 3.559e-05 0.0002826
587 ACTIVATION OF MAPKK ACTIVITY 20 52 3.596e-05 0.000285
588 REGULATION OF CELLULAR COMPONENT SIZE 79 337 3.701e-05 0.0002929
589 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 41 145 3.746e-05 0.0002959
590 REGULATION OF METANEPHROS DEVELOPMENT 12 23 3.806e-05 0.0003002
591 REGULATION OF SODIUM ION TRANSPORT 26 77 3.836e-05 0.000302
592 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 16 37 3.997e-05 0.0003125
593 CARDIAC MUSCLE CELL ACTION POTENTIAL 16 37 3.997e-05 0.0003125
594 PROTEIN LOCALIZATION 333 1805 3.977e-05 0.0003125
595 AXON EXTENSION 16 37 3.997e-05 0.0003125
596 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 14 4.066e-05 0.0003174
597 POSITIVE REGULATION OF SECRETION 85 370 4.179e-05 0.0003257
598 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 11 20 4.255e-05 0.0003311
599 REGULATION OF CELL ACTIVATION 106 484 4.318e-05 0.0003344
600 SMOOTH MUSCLE CELL DIFFERENTIATION 14 30 4.319e-05 0.0003344
601 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 14 30 4.319e-05 0.0003344
602 NEGATIVE REGULATION OF ION TRANSPORT 37 127 4.359e-05 0.0003369
603 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 17 41 4.447e-05 0.000342
604 REGULATION OF MEMBRANE DEPOLARIZATION 17 41 4.447e-05 0.000342
605 AORTA DEVELOPMENT 17 41 4.447e-05 0.000342
606 INTEGRIN MEDIATED SIGNALING PATHWAY 27 82 4.547e-05 0.0003491
607 RESPONSE TO EXTRACELLULAR STIMULUS 98 441 4.586e-05 0.0003515
608 IMMUNE RESPONSE 214 1100 4.597e-05 0.0003518
609 B CELL ACTIVATION 38 132 4.62e-05 0.000353
610 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 22 61 4.776e-05 0.0003643
611 REGULATION OF PEPTIDE TRANSPORT 63 256 4.875e-05 0.0003713
612 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 20 53 4.957e-05 0.0003756
613 CYTOSOLIC CALCIUM ION TRANSPORT 20 53 4.957e-05 0.0003756
614 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 20 53 4.957e-05 0.0003756
615 DEFENSE RESPONSE 236 1231 5.071e-05 0.0003837
616 NEGATIVE REGULATION OF NEURON DEATH 46 171 5.123e-05 0.000387
617 RESPONSE TO FLUID SHEAR STRESS 15 34 5.232e-05 0.0003939
618 REGULATION OF MESENCHYMAL CELL PROLIFERATION 15 34 5.232e-05 0.0003939
619 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 13 27 5.391e-05 0.0004039
620 HIPPO SIGNALING 13 27 5.391e-05 0.0004039
621 REGULATION OF CATENIN IMPORT INTO NUCLEUS 13 27 5.391e-05 0.0004039
622 REGULATION OF NEURON DEATH 62 252 5.615e-05 0.0004201
623 MUSCLE ORGAN MORPHOGENESIS 24 70 5.69e-05 0.0004243
624 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 24 70 5.69e-05 0.0004243
625 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 44 162 5.762e-05 0.000429
626 FORMATION OF PRIMARY GERM LAYER 33 110 5.848e-05 0.0004347
627 POSITIVE REGULATION OF CATABOLIC PROCESS 89 395 5.943e-05 0.0004396
628 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 16 38 5.935e-05 0.0004396
629 REGULATION OF RENAL SYSTEM PROCESS 16 38 5.935e-05 0.0004396
630 NEGATIVE REGULATION OF CELL CYCLE 96 433 5.982e-05 0.0004418
631 REGULATION OF VASOCONSTRICTION 23 66 6.041e-05 0.0004454
632 RESPONSE TO KETONE 48 182 6.122e-05 0.0004507
633 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 51 197 6.208e-05 0.0004563
634 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 26 79 6.299e-05 0.0004616
635 REGULATION OF STRIATED MUSCLE CONTRACTION 26 79 6.299e-05 0.0004616
636 CARDIAC VENTRICLE MORPHOGENESIS 22 62 6.35e-05 0.0004646
637 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 42 153 6.442e-05 0.0004706
638 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 24 6.562e-05 0.0004786
639 INTERACTION WITH HOST 38 134 6.609e-05 0.0004812
640 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 14 31 6.78e-05 0.0004929
641 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 19 50 6.802e-05 0.0004938
642 NEGATIVE REGULATION OF CATABOLIC PROCESS 52 203 7.132e-05 0.0005169
643 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 50 193 7.147e-05 0.0005172
644 POSITIVE REGULATION OF CYTOKINE PRODUCTION 84 370 7.168e-05 0.0005179
645 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 27 84 7.292e-05 0.000526
646 NEPHRON EPITHELIUM DEVELOPMENT 29 93 7.453e-05 0.0005368
647 RESPONSE TO FIBROBLAST GROWTH FACTOR 34 116 7.644e-05 0.0005489
648 FEMALE SEX DIFFERENTIATION 34 116 7.644e-05 0.0005489
649 REGULATION OF BROWN FAT CELL DIFFERENTIATION 8 12 7.742e-05 0.0005525
650 CHONDROCYTE DEVELOPMENT 11 21 7.71e-05 0.0005525
651 CARTILAGE MORPHOGENESIS 8 12 7.742e-05 0.0005525
652 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 12 7.742e-05 0.0005525
653 REGULATION OF PROTEIN KINASE B SIGNALING 35 121 8.128e-05 0.0005791
654 POST EMBRYONIC DEVELOPMENT 28 89 8.275e-05 0.0005887
655 REGULATION OF MUSCLE ADAPTATION 22 63 8.371e-05 0.0005947
656 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 10 18 8.591e-05 0.0006084
657 INOSITOL PHOSPHATE MEDIATED SIGNALING 10 18 8.591e-05 0.0006084
658 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 13 28 8.668e-05 0.000612
659 REGULATION OF FATTY ACID OXIDATION 13 28 8.668e-05 0.000612
660 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 9 15 8.791e-05 0.0006198
661 INFLAMMATORY RESPONSE 99 454 9.036e-05 0.0006354
662 ENDOMEMBRANE SYSTEM ORGANIZATION 101 465 9.04e-05 0.0006354
663 CEREBRAL CORTEX CELL MIGRATION 17 43 9.125e-05 0.0006404
664 WNT SIGNALING PATHWAY 80 351 9.161e-05 0.000641
665 HEART PROCESS 27 85 9.158e-05 0.000641
666 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 34 117 9.224e-05 0.0006444
667 ARTERY MORPHOGENESIS 19 51 9.31e-05 0.0006495
668 GLIOGENESIS 46 175 9.391e-05 0.0006541
669 PROTEIN DEPHOSPHORYLATION 49 190 9.479e-05 0.0006593
670 REGULATION OF ORGANELLE ORGANIZATION 225 1178 9.603e-05 0.0006669
671 ION TRANSMEMBRANE TRANSPORT 164 822 9.782e-05 0.0006773
672 NEGATIVE REGULATION OF PROTEIN SECRETION 32 108 9.772e-05 0.0006773
673 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 26 81 0.000101 0.0006982
674 ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 23 68 0.0001023 0.0007049
675 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 23 68 0.0001023 0.0007049
676 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 28 90 0.0001029 0.0007085
677 SALIVARY GLAND DEVELOPMENT 14 32 0.0001038 0.0007111
678 ENDOCARDIAL CUSHION DEVELOPMENT 14 32 0.0001038 0.0007111
679 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 14 32 0.0001038 0.0007111
680 MEMBRANE ASSEMBLY 12 25 0.0001088 0.0007434
681 CELLULAR EXTRAVASATION 12 25 0.0001088 0.0007434
682 HINDBRAIN DEVELOPMENT 38 137 0.0001107 0.0007546
683 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 34 118 0.0001109 0.0007546
684 CELLULAR MACROMOLECULE LOCALIZATION 234 1234 0.0001108 0.0007546
685 NEUROMUSCULAR JUNCTION DEVELOPMENT 15 36 0.0001162 0.0007858
686 REGULATION OF GLUCOSE IMPORT 21 60 0.0001161 0.0007858
687 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 15 36 0.0001162 0.0007858
688 CORTICAL CYTOSKELETON ORGANIZATION 15 36 0.0001162 0.0007858
689 RESPONSE TO HYDROGEN PEROXIDE 32 109 0.0001185 8e-04
690 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 24 73 0.0001211 0.0008169
691 SMAD PROTEIN SIGNAL TRANSDUCTION 20 56 0.0001218 0.0008199
692 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 85 381 0.0001231 0.0008277
693 PEPTIDYL TYROSINE DEPHOSPHORYLATION 30 100 0.0001243 0.0008343
694 REGULATION OF EMBRYONIC DEVELOPMENT 33 114 0.000126 0.000845
695 NEGATIVE REGULATION OF JAK STAT CASCADE 17 44 0.0001278 0.0008546
696 NEGATIVE REGULATION OF STAT CASCADE 17 44 0.0001278 0.0008546
697 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 171 867 0.0001295 0.0008648
698 GLYCOSPHINGOLIPID METABOLIC PROCESS 23 69 0.0001316 0.0008759
699 POSITIVE REGULATION OF AXONOGENESIS 23 69 0.0001316 0.0008759
700 NEGATIVE REGULATION OF MUSCLE CONTRACTION 11 22 0.0001331 0.0008834
701 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 11 22 0.0001331 0.0008834
702 STEM CELL DIVISION 13 29 0.0001354 0.0008954
703 NEGATIVE REGULATION OF RECEPTOR ACTIVITY 13 29 0.0001354 0.0008954
704 RESPONSE TO ESTROGEN 54 218 0.0001357 0.0008954
705 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 54 218 0.0001357 0.0008954
706 MYELOID LEUKOCYTE DIFFERENTIATION 29 96 0.0001398 0.0009213
707 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 27 87 0.0001422 0.0009253
708 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 27 87 0.0001422 0.0009253
709 HORMONE MEDIATED SIGNALING PATHWAY 42 158 0.0001416 0.0009253
710 VIRAL ENTRY INTO HOST CELL 27 87 0.0001422 0.0009253
711 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 27 87 0.0001422 0.0009253
712 TISSUE REMODELING 27 87 0.0001422 0.0009253
713 MOVEMENT IN HOST ENVIRONMENT 27 87 0.0001422 0.0009253
714 ENTRY INTO HOST 27 87 0.0001422 0.0009253
715 ENTRY INTO HOST CELL 27 87 0.0001422 0.0009253
716 CAMERA TYPE EYE MORPHOGENESIS 30 101 0.0001514 0.0009841
717 REGULATION OF DENDRITE MORPHOGENESIS 24 74 0.0001538 0.0009965
718 ACTIN MEDIATED CELL CONTRACTION 24 74 0.0001538 0.0009965
719 NEURON RECOGNITION 14 33 0.0001552 0.001003
720 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 14 33 0.0001552 0.001003
721 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 10 19 0.0001567 0.00101
722 GLOMERULAR EPITHELIUM DEVELOPMENT 10 19 0.0001567 0.00101
723 CYTOKINE PRODUCTION 34 120 0.0001588 0.001022
724 SEX DIFFERENTIATION 63 266 0.0001591 0.001022
725 AMMONIUM TRANSPORT 20 57 0.0001611 0.001034
726 STEROID HORMONE MEDIATED SIGNALING PATHWAY 35 125 0.0001655 0.001061
727 MYOBLAST DIFFERENTIATION 15 37 0.0001682 0.001073
728 REGULATION OF MUSCLE HYPERTROPHY 15 37 0.0001682 0.001073
729 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 15 37 0.0001682 0.001073
730 NEURON PROJECTION EXTENSION 19 53 0.0001687 0.001075
731 ACTIN FILAMENT BUNDLE ORGANIZATION 18 49 0.0001742 0.001097
732 HEART TRABECULA MORPHOGENESIS 12 26 0.0001742 0.001097
733 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 9 16 0.0001739 0.001097
734 EXTRACELLULAR MATRIX ASSEMBLY 9 16 0.0001739 0.001097
735 REGULATION OF MONONUCLEAR CELL MIGRATION 9 16 0.0001739 0.001097
736 CARDIOBLAST DIFFERENTIATION 8 13 0.0001744 0.001097
737 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 12 26 0.0001742 0.001097
738 VASODILATION 12 26 0.0001742 0.001097
739 REGULATION OF AMINO ACID TRANSPORT 12 26 0.0001742 0.001097
740 CARDIAC SEPTUM MORPHOGENESIS 18 49 0.0001742 0.001097
741 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 25 79 0.0001755 0.001102
742 POSITIVE REGULATION OF RECEPTOR ACTIVITY 17 45 0.0001766 0.001105
743 EXOCRINE SYSTEM DEVELOPMENT 17 45 0.0001766 0.001105
744 ENDOCHONDRAL BONE MORPHOGENESIS 17 45 0.0001766 0.001105
745 PATTERN SPECIFICATION PROCESS 91 418 0.0001807 0.001129
746 REGULATION OF NEUROTRANSMITTER LEVELS 48 190 0.0001891 0.001178
747 NEGATIVE REGULATION OF IMMUNE RESPONSE 34 121 0.0001892 0.001178
748 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 24 75 0.000194 0.001205
749 MULTI ORGANISM BEHAVIOR 24 75 0.000194 0.001205
750 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 53 216 0.000201 0.001247
751 CELL MATURATION 36 131 0.0002023 0.001254
752 POSITIVE REGULATION OF PROTEIN SECRETION 52 211 0.0002045 0.001264
753 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 52 211 0.0002045 0.001264
754 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 13 30 0.0002058 0.001269
755 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 13 30 0.0002058 0.001269
756 RESPONSE TO AMINO ACID 32 112 0.0002064 0.001271
757 GLIAL CELL DIFFERENTIATION 37 136 0.0002075 0.001276
758 REGULATION OF IMMUNE RESPONSE 168 858 0.0002147 0.001318
759 LIPID METABOLIC PROCESS 219 1158 0.000215 0.001318
760 LEUKOCYTE CHEMOTAXIS 33 117 0.0002161 0.001323
761 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 41 156 0.0002198 0.001344
762 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 11 23 0.0002202 0.001345
763 CARDIAC MUSCLE TISSUE MORPHOGENESIS 19 54 0.0002236 0.001364
764 FOREBRAIN NEURON DEVELOPMENT 14 34 0.0002272 0.001382
765 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 14 34 0.0002272 0.001382
766 VISUAL BEHAVIOR 18 50 0.0002339 0.001421
767 REGULATION OF ACTION POTENTIAL 15 38 0.0002391 0.001449
768 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 15 38 0.0002391 0.001449
769 REGULATION OF PROTEIN TARGETING 70 307 0.0002401 0.001453
770 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 17 46 0.0002409 0.001456
771 CIRCADIAN RHYTHM 37 137 0.0002434 0.001467
772 NEGATIVE REGULATION OF GTPASE ACTIVITY 16 42 0.0002431 0.001467
773 REGULATION OF NEURON APOPTOTIC PROCESS 48 192 0.0002463 0.001482
774 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 40 152 0.0002531 0.001521
775 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 44 172 0.0002545 0.001528
776 RESPONSE TO CAMP 30 104 0.0002675 0.001602
777 REGULATION OF INTERLEUKIN 6 PRODUCTION 30 104 0.0002675 0.001602
778 RESPONSE TO PROTOZOAN 10 20 0.0002708 0.001614
779 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 12 27 0.0002705 0.001614
780 SUBSTRATE DEPENDENT CELL MIGRATION 12 27 0.0002705 0.001614
781 MELANOCYTE DIFFERENTIATION 10 20 0.0002708 0.001614
782 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 35 128 0.0002733 0.001626
783 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 20 59 0.0002743 0.001628
784 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 20 59 0.0002743 0.001628
785 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 47 188 0.000284 0.001683
786 PLACENTA DEVELOPMENT 37 138 0.0002846 0.001685
787 REGULATION OF KIDNEY DEVELOPMENT 19 55 0.0002935 0.001733
788 CRANIAL SKELETAL SYSTEM DEVELOPMENT 19 55 0.0002935 0.001733
789 NEGATIVE REGULATION OF CELL ACTIVATION 41 158 0.0002941 0.001735
790 NERVE DEVELOPMENT 22 68 0.0002963 0.001745
791 RESPONSE TO RADIATION 89 413 0.0003028 0.001781
792 METENCEPHALON DEVELOPMENT 29 100 0.0003042 0.001787
793 MACROPHAGE ACTIVATION 13 31 0.0003055 0.001793
794 REGULATION OF DOPAMINE METABOLIC PROCESS 9 17 0.0003197 0.001866
795 NEGATIVE REGULATION OF PLATELET ACTIVATION 9 17 0.0003197 0.001866
796 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 9 17 0.0003197 0.001866
797 REGULATION OF CATECHOLAMINE METABOLIC PROCESS 9 17 0.0003197 0.001866
798 ODONTOGENESIS 30 105 0.0003209 0.001871
799 ENSHEATHMENT OF NEURONS 27 91 0.000323 0.001879
800 AXON ENSHEATHMENT 27 91 0.000323 0.001879
801 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 17 47 0.0003245 0.001885
802 REGULATION OF AXON GUIDANCE 15 39 0.0003345 0.001936
803 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 15 39 0.0003345 0.001936
804 LONG TERM SYNAPTIC POTENTIATION 15 39 0.0003345 0.001936
805 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 23 73 0.0003371 0.001946
806 ASSOCIATIVE LEARNING 23 73 0.0003371 0.001946
807 LIPID MODIFICATION 51 210 0.0003411 0.001967
808 NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 11 0.0003443 0.00198
809 NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 7 11 0.0003443 0.00198
810 STRESS FIBER ASSEMBLY 8 14 0.0003528 0.002005
811 CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY 8 14 0.0003528 0.002005
812 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 11 24 0.000351 0.002005
813 REGULATION OF GLOMERULUS DEVELOPMENT 8 14 0.0003528 0.002005
814 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 20 60 0.0003534 0.002005
815 POSITIVE REGULATION OF FATTY ACID OXIDATION 8 14 0.0003528 0.002005
816 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 20 60 0.0003534 0.002005
817 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 11 24 0.000351 0.002005
818 CAMP CATABOLIC PROCESS 8 14 0.0003528 0.002005
819 CRANIOFACIAL SUTURE MORPHOGENESIS 8 14 0.0003528 0.002005
820 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 8 14 0.0003528 0.002005
821 POSITIVE REGULATION OF CHEMOTAXIS 33 120 0.0003597 0.002038
822 MULTI ORGANISM REPRODUCTIVE PROCESS 172 891 0.0003728 0.00211
823 RESPONSE TO ACTIVITY 22 69 0.0003734 0.002111
824 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 52 216 0.0003758 0.002122
825 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 36 135 0.0003821 0.002152
826 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 36 135 0.0003821 0.002152
827 PROTEIN HOMOOLIGOMERIZATION 58 248 0.0003995 0.002248
828 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 18 52 0.0004085 0.002285
829 RIBONUCLEOTIDE CATABOLIC PROCESS 12 28 0.0004084 0.002285
830 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 12 28 0.0004084 0.002285
831 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 18 52 0.0004085 0.002285
832 REGULATION OF LIPID CATABOLIC PROCESS 18 52 0.0004085 0.002285
833 REGULATION OF CHEMOKINE PRODUCTION 21 65 0.0004118 0.0023
834 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 23 74 0.0004197 0.002342
835 OSTEOBLAST DIFFERENTIATION 34 126 0.0004326 0.002407
836 PROTEIN OLIGOMERIZATION 92 434 0.0004329 0.002407
837 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 17 48 0.0004321 0.002407
838 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 29 102 0.000438 0.002432
839 RETINA DEVELOPMENT IN CAMERA TYPE EYE 35 131 0.0004397 0.002439
840 MYELOID CELL HOMEOSTASIS 26 88 0.0004441 0.002451
841 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 13 32 0.0004436 0.002451
842 BLOOD VESSEL REMODELING 13 32 0.0004436 0.002451
843 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 32 0.0004436 0.002451
844 REGULATION OF AUTOPHAGY 58 249 0.0004452 0.002452
845 CELL AGGREGATION 10 21 0.000447 0.002452
846 LIPID TRANSLOCATION 10 21 0.000447 0.002452
847 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 21 0.000447 0.002452
848 CARTILAGE CONDENSATION 10 21 0.000447 0.002452
849 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 14 36 0.0004597 0.002517
850 POSITIVE REGULATION OF AXON EXTENSION 14 36 0.0004597 0.002517
851 POSITIVE REGULATION OF CELL MATRIX ADHESION 15 40 0.0004607 0.002519
852 EAR MORPHOGENESIS 31 112 0.0004729 0.002583
853 REGULATION OF CELL CELL ADHESION 82 380 0.000489 0.002667
854 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 33 122 0.0004974 0.00271
855 SENSORY PERCEPTION OF PAIN 23 75 0.0005196 0.002823
856 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 38 147 0.00052 0.002823
857 INTRINSIC APOPTOTIC SIGNALING PATHWAY 39 152 0.0005192 0.002823
858 REGULATION OF CALCIUM ION IMPORT 29 103 0.0005225 0.002834
859 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 25 0.0005412 0.002932
860 SINGLE ORGANISM CELLULAR LOCALIZATION 172 898 0.0005467 0.002958
861 OVULATION 9 18 0.0005535 0.002988
862 PROTEIN COMPLEX SUBUNIT ORGANIZATION 277 1527 0.0005533 0.002988
863 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 17 49 0.0005692 0.003069
864 LUNG MORPHOGENESIS 16 45 0.0006015 0.003239
865 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 29 104 0.0006211 0.003341
866 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 15 41 0.0006256 0.003357
867 GOLGI TO PLASMA MEMBRANE TRANSPORT 15 41 0.0006256 0.003357
868 NEGATIVE REGULATION OF WOUND HEALING 19 58 0.000629 0.003372
869 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 13 33 0.0006311 0.003379
870 ACTIN POLYMERIZATION OR DEPOLYMERIZATION 14 37 0.0006372 0.003404
871 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 14 37 0.0006372 0.003404
872 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 8 15 0.0006555 0.003498
873 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 33 124 0.0006798 0.003623
874 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 27 95 0.0006826 0.003634
875 REGULATION OF LEUKOCYTE MIGRATION 38 149 0.0006884 0.003657
876 REGULATION OF CYTOKINE SECRETION 38 149 0.0006884 0.003657
877 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 10 22 0.0007085 0.003738
878 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 10 22 0.0007085 0.003738
879 SOMATIC STEM CELL DIVISION 10 22 0.0007085 0.003738
880 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 10 22 0.0007085 0.003738
881 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 10 22 0.0007085 0.003738
882 MONOAMINE TRANSPORT 10 22 0.0007085 0.003738
883 LIMBIC SYSTEM DEVELOPMENT 28 100 0.0007115 0.003749
884 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 7 12 0.000718 0.003758
885 ROUNDABOUT SIGNALING PATHWAY 7 12 0.000718 0.003758
886 AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 12 0.000718 0.003758
887 REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 7 12 0.000718 0.003758
888 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 7 12 0.000718 0.003758
889 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 7 12 0.000718 0.003758
890 RESPONSE TO OSMOTIC STRESS 20 63 0.0007211 0.003766
891 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 20 63 0.0007211 0.003766
892 CELLULAR RESPONSE TO CAMP 17 50 0.0007419 0.003861
893 STAT CASCADE 17 50 0.0007419 0.003861
894 JAK STAT CASCADE 17 50 0.0007419 0.003861
895 REGULATION OF APOPTOTIC SIGNALING PATHWAY 78 363 0.0007526 0.003913
896 GASTRULATION 39 155 0.0007823 0.004061
897 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 23 77 0.0007829 0.004061
898 ENTRAINMENT OF CIRCADIAN CLOCK 11 26 0.0008104 0.004194
899 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 11 26 0.0008104 0.004194
900 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 15 42 0.0008381 0.004309
901 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 15 42 0.0008381 0.004309
902 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 63 282 0.0008353 0.004309
903 DENDRITE MORPHOGENESIS 15 42 0.0008381 0.004309
904 POSITIVE REGULATION OF GLUCOSE TRANSPORT 15 42 0.0008381 0.004309
905 CALCIUM ION IMPORT INTO CYTOSOL 15 42 0.0008381 0.004309
906 MEMBRANE BIOGENESIS 12 30 0.0008647 0.004416
907 NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 12 30 0.0008647 0.004416
908 RESPONSE TO BACTERIUM 107 528 0.0008613 0.004416
909 BROWN FAT CELL DIFFERENTIATION 12 30 0.0008647 0.004416
910 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 12 30 0.0008647 0.004416
911 OSTEOCLAST DIFFERENTIATION 12 30 0.0008647 0.004416
912 TRANSITION METAL ION HOMEOSTASIS 29 106 0.0008683 0.00443
913 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 14 38 0.0008694 0.004431
914 POSITIVE REGULATION OF SODIUM ION TRANSPORT 13 34 0.0008811 0.004478
915 CELLULAR LIPID METABOLIC PROCESS 173 913 0.0008815 0.004478
916 PROTEIN AUTOPHOSPHORYLATION 46 192 0.0008813 0.004478
917 CELLULAR RESPONSE TO KETONE 22 73 0.000884 0.004486
918 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 30 111 0.0008875 0.004498
919 REGULATION OF FATTY ACID METABOLIC PROCESS 25 87 0.0008894 0.004503
920 TRANSMEMBRANE TRANSPORT 204 1098 0.0008999 0.004551
921 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 9 19 0.0009106 0.004586
922 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 9 19 0.0009106 0.004586
923 ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD 9 19 0.0009106 0.004586
924 FIBRIL ORGANIZATION 9 19 0.0009106 0.004586
925 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 32 121 0.0009123 0.004589
926 INNER EAR MORPHOGENESIS 26 92 0.0009322 0.004684
927 RENAL TUBULE DEVELOPMENT 23 78 0.0009532 0.004785
928 STEM CELL PROLIFERATION 19 60 0.001003 0.005025
929 LEUKOCYTE HOMEOSTASIS 19 60 0.001003 0.005025
930 EMBRYONIC PLACENTA DEVELOPMENT 24 83 0.001014 0.005067
931 RESPONSE TO FATTY ACID 24 83 0.001014 0.005067
932 AMINOGLYCAN BIOSYNTHETIC PROCESS 29 107 0.001021 0.005099
933 GLYCEROLIPID METABOLIC PROCESS 76 356 0.001057 0.005272
934 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 33 127 0.001064 0.005294
935 ESTABLISHMENT OF CELL POLARITY 25 88 0.001066 0.005294
936 LEUKOCYTE PROLIFERATION 25 88 0.001066 0.005294
937 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 104 514 0.001066 0.005294
938 NEGATIVE REGULATION OF HORMONE SECRETION 22 74 0.00108 0.00536
939 REGULATION OF OSTEOBLAST PROLIFERATION 10 23 0.001084 0.005361
940 TRABECULA FORMATION 10 23 0.001084 0.005361
941 STRIATED MUSCLE ADAPTATION 10 23 0.001084 0.005361
942 ANTERIOR POSTERIOR PATTERN SPECIFICATION 46 194 0.00111 0.005484
943 REGULATION OF DENDRITIC SPINE DEVELOPMENT 18 56 0.001111 0.005484
944 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 41 168 0.001114 0.005493
945 DENDRITIC CELL CHEMOTAXIS 8 16 0.001137 0.005552
946 MORPHOGENESIS OF AN ENDOTHELIUM 8 16 0.001137 0.005552
947 REGULATION OF MACROPHAGE CHEMOTAXIS 8 16 0.001137 0.005552
948 RESPONSE TO EPINEPHRINE 8 16 0.001137 0.005552
949 STRIATUM DEVELOPMENT 8 16 0.001137 0.005552
950 CELLULAR RESPONSE TO LEPTIN STIMULUS 8 16 0.001137 0.005552
951 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 8 16 0.001137 0.005552
952 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 8 16 0.001137 0.005552
953 REGULATION OF FATTY ACID BETA OXIDATION 8 16 0.001137 0.005552
954 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 27 98 0.001146 0.005585
955 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 27 98 0.001146 0.005585
956 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 14 39 0.001169 0.00569
957 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 11 27 0.001182 0.005721
958 EXCITATORY POSTSYNAPTIC POTENTIAL 11 27 0.001182 0.005721
959 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 11 27 0.001182 0.005721
960 AXIS ELONGATION 11 27 0.001182 0.005721
961 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 11 27 0.001182 0.005721
962 MUCOPOLYSACCHARIDE METABOLIC PROCESS 29 108 0.001197 0.005791
963 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 47 200 0.001207 0.005833
964 NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 13 35 0.001209 0.005836
965 REGULATION OF ANION TRANSPORT 35 138 0.001216 0.005864
966 MATERNAL PLACENTA DEVELOPMENT 12 31 0.001218 0.005866
967 NEURAL PRECURSOR CELL PROLIFERATION 21 70 0.001222 0.005872
968 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 65 297 0.001221 0.005872
969 MESODERM DEVELOPMENT 31 118 0.001223 0.005872
970 REGULATION OF PHOSPHATASE ACTIVITY 33 128 0.001228 0.00589
971 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 19 61 0.001253 0.006004
972 REGULATION OF VASCULOGENESIS 7 13 0.001352 0.006387
973 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 7 13 0.001352 0.006387
974 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 7 13 0.001352 0.006387
975 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 0.001352 0.006387
976 NEGATIVE REGULATION OF COAGULATION 16 48 0.001338 0.006387
977 LEUKOCYTE TETHERING OR ROLLING 7 13 0.001352 0.006387
978 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 7 13 0.001352 0.006387
979 POSITIVE REGULATION OF WOUND HEALING 16 48 0.001338 0.006387
980 REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 7 13 0.001352 0.006387
981 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 7 13 0.001352 0.006387
982 NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 7 13 0.001352 0.006387
983 EXTRACELLULAR FIBRIL ORGANIZATION 7 13 0.001352 0.006387
984 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 7 13 0.001352 0.006387
985 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 7 13 0.001352 0.006387
986 RESPONSE TO BIOTIC STIMULUS 167 886 0.001361 0.006423
987 REGULATION OF MULTICELLULAR ORGANISM GROWTH 20 66 0.00138 0.006491
988 MESODERM MORPHOGENESIS 20 66 0.00138 0.006491
989 POSITIVE REGULATION OF PROTEIN IMPORT 28 104 0.001379 0.006491
990 CIRCADIAN REGULATION OF GENE EXPRESSION 18 57 0.001397 0.006561
991 MYOTUBE DIFFERENTIATION 18 57 0.001397 0.006561
992 REGULATION OF CAMP METABOLIC PROCESS 33 129 0.001414 0.006632
993 GLUCOSE HOMEOSTASIS 41 170 0.001421 0.006652
994 CARBOHYDRATE HOMEOSTASIS 41 170 0.001421 0.006652
995 EMBRYONIC HEMOPOIESIS 9 20 0.001434 0.006686
996 RELAXATION OF MUSCLE 9 20 0.001434 0.006686
997 INTRACELLULAR LIPID TRANSPORT 9 20 0.001434 0.006686
998 REGULATION OF RECEPTOR RECYCLING 9 20 0.001434 0.006686
999 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 15 44 0.001449 0.006749
1000 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 24 85 0.001458 0.006783
1001 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 21 71 0.001491 0.006933
1002 MIDBRAIN DEVELOPMENT 25 90 0.001512 0.007015
1003 REGULATION OF GLIOGENESIS 25 90 0.001512 0.007015
1004 NEUROTRANSMITTER TRANSPORT 38 155 0.001516 0.007018
1005 REGULATION OF CELL PROJECTION ASSEMBLY 38 155 0.001516 0.007018
1006 INORGANIC ION TRANSMEMBRANE TRANSPORT 115 583 0.00154 0.007122
1007 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 17 53 0.001551 0.007145
1008 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 17 53 0.001551 0.007145
1009 FORELIMB MORPHOGENESIS 14 40 0.00155 0.007145
1010 MESONEPHRIC TUBULE MORPHOGENESIS 17 53 0.001551 0.007145
1011 REGULATION OF DEFENSE RESPONSE 145 759 0.001599 0.00736
1012 PHOTOPERIODISM 10 24 0.001608 0.007378
1013 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 10 24 0.001608 0.007378
1014 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 10 24 0.001608 0.007378
1015 OLFACTORY LOBE DEVELOPMENT 13 36 0.001633 0.007477
1016 SEMAPHORIN PLEXIN SIGNALING PATHWAY 13 36 0.001633 0.007477
1017 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 11 28 0.001682 0.007667
1018 PATTERNING OF BLOOD VESSELS 12 32 0.001682 0.007667
1019 NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 12 32 0.001682 0.007667
1020 REGULATION OF SPROUTING ANGIOGENESIS 11 28 0.001682 0.007667
1021 PURINERGIC RECEPTOR SIGNALING PATHWAY 11 28 0.001682 0.007667
1022 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 16 49 0.001711 0.007781
1023 REGULATION OF IMMUNE EFFECTOR PROCESS 87 424 0.001709 0.007781
1024 POSITIVE REGULATION OF DNA REPLICATION 24 86 0.001736 0.007888
1025 RESPONSE TO ESTRADIOL 36 146 0.001784 0.008097
1026 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 97 482 0.001831 0.008287
1027 POSITIVE REGULATION OF CYTOKINE SECRETION 26 96 0.001831 0.008287
1028 REGULATION OF LEUKOCYTE CHEMOTAXIS 26 96 0.001831 0.008287
1029 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 34 136 0.001839 0.008316
1030 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 27 101 0.001861 0.008354
1031 BRANCH ELONGATION OF AN EPITHELIUM 8 17 0.001864 0.008354
1032 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 8 17 0.001864 0.008354
1033 REGULATION OF PROTEIN KINASE A SIGNALING 8 17 0.001864 0.008354
1034 REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE 8 17 0.001864 0.008354
1035 NEGATIVE REGULATION OF BINDING 33 131 0.001861 0.008354
1036 NEGATIVE REGULATION OF LIPID STORAGE 8 17 0.001864 0.008354
1037 DEFINITIVE HEMOPOIESIS 8 17 0.001864 0.008354
1038 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 8 17 0.001864 0.008354
1039 ENDOTHELIAL CELL DEVELOPMENT 15 45 0.001873 0.008371
1040 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 15 45 0.001873 0.008371
1041 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 15 45 0.001873 0.008371
1042 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 82 397 0.001879 0.008391
1043 VENTRICULAR SEPTUM DEVELOPMENT 17 54 0.001948 0.008691
1044 KIDNEY MORPHOGENESIS 23 82 0.001992 0.008879
1045 REGULATION OF LIPID STORAGE 14 41 0.00203 0.009038
1046 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 24 87 0.002058 0.009151
1047 REGULATION OF PHAGOCYTOSIS 20 68 0.002059 0.009151
1048 REGULATION OF LEUKOCYTE DIFFERENTIATION 52 232 0.002092 0.009286
1049 REGULATION OF PROTEIN CATABOLIC PROCESS 81 393 0.002121 0.009409
1050 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 16 50 0.002167 0.009527
1051 DENDRITIC CELL MIGRATION 9 21 0.002174 0.009527
1052 CORONARY VASCULATURE DEVELOPMENT 13 37 0.002172 0.009527
1053 REGULATION OF ORGANIC ACID TRANSPORT 16 50 0.002167 0.009527
1054 MATING 13 37 0.002172 0.009527
1055 REGULATION OF COENZYME METABOLIC PROCESS 16 50 0.002167 0.009527
1056 REGULATION OF MEMBRANE LIPID DISTRIBUTION 13 37 0.002172 0.009527
1057 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 9 21 0.002174 0.009527
1058 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 9 21 0.002174 0.009527
1059 REGULATION OF COFACTOR METABOLIC PROCESS 16 50 0.002167 0.009527
1060 IMPORT INTO CELL 13 37 0.002172 0.009527
1061 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 16 50 0.002167 0.009527
1062 SIALYLATION 9 21 0.002174 0.009527
1063 POSITIVE REGULATION OF PROTEIN BINDING 21 73 0.002183 0.009529
1064 POSITIVE REGULATION OF STAT CASCADE 21 73 0.002183 0.009529
1065 PANCREAS DEVELOPMENT 21 73 0.002183 0.009529
1066 POSITIVE REGULATION OF JAK STAT CASCADE 21 73 0.002183 0.009529
1067 REGULATION OF DEPHOSPHORYLATION 38 158 0.002187 0.009539
1068 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 48 211 0.002209 0.009624
1069 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 37 153 0.002241 0.009752
1070 POSITIVE REGULATION OF CELL CYCLE 70 332 0.002265 0.009849
1071 NEGATIVE REGULATION OF JNK CASCADE 12 33 0.002283 0.009919
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOSKELETAL PROTEIN BINDING 231 819 1.334e-22 1.239e-19
2 ACTIN BINDING 133 393 1.182e-20 3.92e-18
3 MOLECULAR FUNCTION REGULATOR 331 1353 1.266e-20 3.92e-18
4 RECEPTOR BINDING 352 1476 5.696e-20 1.323e-17
5 ENZYME BINDING 395 1737 1.477e-18 2.745e-16
6 PROTEIN COMPLEX BINDING 232 935 2.243e-15 3.473e-13
7 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 82 228 6.333e-15 8.404e-13
8 MACROMOLECULAR COMPLEX BINDING 317 1399 9.77e-15 1.135e-12
9 GROWTH FACTOR BINDING 54 123 2.165e-14 2.235e-12
10 GLYCOSAMINOGLYCAN BINDING 73 205 3.405e-13 3.163e-11
11 CALCIUM ION BINDING 176 697 1.272e-12 1.074e-10
12 KINASE ACTIVITY 204 842 1.397e-12 1.082e-10
13 PROTEIN DOMAIN SPECIFIC BINDING 161 624 1.871e-12 1.337e-10
14 PROTEIN KINASE ACTIVITY 164 640 2.12e-12 1.407e-10
15 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 161 629 3.737e-12 2.315e-10
16 KINASE BINDING 156 606 5.049e-12 2.759e-10
17 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 93 303 4.947e-12 2.759e-10
18 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 98 328 7.663e-12 3.955e-10
19 HEPARIN BINDING 58 157 1.608e-11 7.861e-10
20 SULFUR COMPOUND BINDING 76 234 2.159e-11 1.002e-09
21 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 97 329 2.264e-11 1.002e-09
22 ENZYME REGULATOR ACTIVITY 219 959 8.566e-11 3.617e-09
23 IDENTICAL PROTEIN BINDING 264 1209 1.292e-10 5.219e-09
24 CELL ADHESION MOLECULE BINDING 63 186 1.565e-10 6.059e-09
25 REGULATORY REGION NUCLEIC ACID BINDING 190 818 3.781e-10 1.405e-08
26 PROTEIN DIMERIZATION ACTIVITY 250 1149 5.971e-10 2.133e-08
27 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 220 992 1.231e-09 4.234e-08
28 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 89 315 1.623e-09 5.384e-08
29 SMAD BINDING 32 72 2.861e-09 8.921e-08
30 ENZYME ACTIVATOR ACTIVITY 120 471 2.881e-09 8.921e-08
31 CYTOKINE BINDING 37 92 5.045e-09 1.512e-07
32 CALMODULIN BINDING 58 179 5.428e-09 1.576e-07
33 PROTEIN HOMODIMERIZATION ACTIVITY 167 722 6.195e-09 1.693e-07
34 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 254 1199 6.044e-09 1.693e-07
35 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 33 81 2.302e-08 6.111e-07
36 BINDING BRIDGING 55 173 2.804e-08 7.236e-07
37 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 29 70 1.043e-07 2.618e-06
38 TRANSFORMING GROWTH FACTOR BETA BINDING 12 16 1.456e-07 3.559e-06
39 SH3 DOMAIN BINDING 40 116 1.914e-07 4.56e-06
40 ACTIN FILAMENT BINDING 41 121 2.331e-07 5.414e-06
41 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 64 226 2.784e-07 6.308e-06
42 INTEGRIN BINDING 37 105 2.921e-07 6.462e-06
43 SIGNAL TRANSDUCER ACTIVITY 336 1731 3.503e-07 7.569e-06
44 SIGNALING ADAPTOR ACTIVITY 29 74 4.317e-07 9.115e-06
45 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 51 168 4.438e-07 9.162e-06
46 ION CHANNEL BINDING 38 111 4.728e-07 9.489e-06
47 TRANSCRIPTION FACTOR BINDING 122 524 4.801e-07 9.489e-06
48 CATION CHANNEL ACTIVITY 78 298 5.227e-07 1.012e-05
49 RECEPTOR SIGNALING PROTEIN ACTIVITY 51 172 9.794e-07 1.857e-05
50 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 132 588 1.365e-06 2.537e-05
51 ZINC ION BINDING 233 1155 1.497e-06 2.726e-05
52 PROTEIN SERINE THREONINE KINASE ACTIVITY 105 445 1.548e-06 2.765e-05
53 RIBONUCLEOTIDE BINDING 353 1860 1.672e-06 2.93e-05
54 LIPID BINDING 144 657 1.901e-06 3.27e-05
55 PROTEIN TYROSINE KINASE ACTIVITY 51 176 2.08e-06 3.513e-05
56 DOUBLE STRANDED DNA BINDING 163 764 2.246e-06 3.727e-05
57 TRANSITION METAL ION BINDING 274 1400 2.362e-06 3.783e-05
58 PHOSPHOLIPID BINDING 88 360 2.351e-06 3.783e-05
59 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 25 64 2.847e-06 4.483e-05
60 PHOSPHORIC ESTER HYDROLASE ACTIVITY 89 368 3.298e-06 5.106e-05
61 CYTOKINE RECEPTOR ACTIVITY 31 89 3.455e-06 5.261e-05
62 GTPASE BINDING 73 295 1.049e-05 0.0001572
63 WNT PROTEIN BINDING 15 31 1.332e-05 0.0001918
64 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 30 90 1.342e-05 0.0001918
65 CORECEPTOR ACTIVITY 17 38 1.331e-05 0.0001918
66 COLLAGEN BINDING 24 65 1.392e-05 0.0001959
67 PROTEIN KINASE A BINDING 18 42 1.545e-05 0.0002142
68 HISTONE ACETYLTRANSFERASE BINDING 14 28 1.609e-05 0.0002198
69 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 104 464 1.873e-05 0.0002522
70 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 33 105 2.054e-05 0.0002726
71 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 95 417 2.166e-05 0.0002834
72 GROWTH FACTOR RECEPTOR BINDING 38 129 2.64e-05 0.0003406
73 ACTININ BINDING 14 29 2.677e-05 0.0003406
74 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 26 76 2.965e-05 0.0003722
75 KINASE INHIBITOR ACTIVITY 29 89 3.013e-05 0.0003732
76 GATED CHANNEL ACTIVITY 77 325 3.145e-05 0.0003845
77 SEQUENCE SPECIFIC DNA BINDING 204 1037 3.493e-05 0.0004214
78 CHANNEL REGULATOR ACTIVITY 38 131 3.845e-05 0.000458
79 SULFURIC ESTER HYDROLASE ACTIVITY 10 17 4.42e-05 0.0005198
80 HORMONE BINDING 23 65 4.589e-05 0.0005329
81 ACTIVATING TRANSCRIPTION FACTOR BINDING 21 57 4.905e-05 0.0005625
82 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 31 101 5.997e-05 0.0006794
83 ALPHA ACTININ BINDING 11 21 7.71e-05 0.0008562
84 ARYLSULFATASE ACTIVITY 8 12 7.742e-05 0.0008562
85 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 9 15 8.791e-05 0.0009497
86 STEROID HORMONE RECEPTOR ACTIVITY 21 59 8.791e-05 0.0009497
87 EXTRACELLULAR MATRIX BINDING 19 51 9.31e-05 0.0009942
88 VOLTAGE GATED ION CHANNEL ACTIVITY 49 190 9.479e-05 0.001001
89 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 28 90 0.0001029 0.001074
90 TUBULIN BINDING 65 273 0.0001073 0.001108
91 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 25 77 0.0001109 0.001132
92 PEPTIDE HORMONE BINDING 15 36 0.0001162 0.001173
93 CORE PROMOTER BINDING 41 152 0.0001195 0.001193
94 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 36 128 0.0001219 0.001193
95 RECEPTOR ACTIVITY 303 1649 0.0001219 0.001193
96 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 44 167 0.0001243 0.001203
97 WNT ACTIVATED RECEPTOR ACTIVITY 11 22 0.0001331 0.001275
98 ADENYL NUCLEOTIDE BINDING 280 1514 0.000143 0.001355
99 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 46 178 0.0001449 0.001359
100 NITRIC OXIDE SYNTHASE BINDING 10 19 0.0001567 0.001456
101 GTPASE ACTIVITY 59 246 0.0001766 0.001625
102 GROWTH FACTOR ACTIVITY 42 160 0.0001909 0.001739
103 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 30 103 0.0002222 0.002004
104 G PROTEIN COUPLED RECEPTOR BINDING 61 259 0.0002353 0.002102
105 PROTEIN HETERODIMERIZATION ACTIVITY 99 468 0.0002898 0.002564
106 PROTEIN COMPLEX SCAFFOLD 22 68 0.0002963 0.002597
107 AMIDE BINDING 63 272 0.0003059 0.002656
108 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 16 43 0.0003331 0.002865
109 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 0.0003443 0.002935
110 GLUCOCORTICOID RECEPTOR BINDING 8 14 0.0003528 0.002953
111 NEUREXIN FAMILY PROTEIN BINDING 8 14 0.0003528 0.002953
112 GLYCOPROTEIN BINDING 29 101 0.0003657 0.003033
113 RHO GTPASE BINDING 24 78 0.0003756 0.003088
114 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 27 92 0.000392 0.003194
115 MICROTUBULE BINDING 49 201 0.0004014 0.003243
116 KINASE REGULATOR ACTIVITY 46 186 0.0004238 0.003394
117 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 17 48 0.0004321 0.003402
118 PHOSPHOLIPID TRANSPORTER ACTIVITY 17 48 0.0004321 0.003402
119 GUANYL NUCLEOTIDE BINDING 84 390 0.0004475 0.003493
120 VIRUS RECEPTOR ACTIVITY 22 70 0.0004675 0.003619
121 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 11 25 0.0005412 0.004155
122 CORE PROMOTER PROXIMAL REGION DNA BINDING 80 371 0.0005816 0.004428
123 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 35 133 0.0005956 0.004499
124 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 29 104 0.0006211 0.004653
125 PDZ DOMAIN BINDING 26 90 0.0006491 0.004824
126 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 8 15 0.0006555 0.004833
127 PHOSPHATIDYLINOSITOL BINDING 48 200 0.0006631 0.004837
128 TRANSCRIPTION COREPRESSOR ACTIVITY 52 221 0.0006664 0.004837
129 PROTEIN TYROSINE KINASE BINDING 18 54 0.000686 0.00494
130 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 17 50 0.0007419 0.005301
131 RAB GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 12 30 0.0008647 0.006132
132 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 17 51 0.0009574 0.006738
133 METALLOPEPTIDASE ACTIVITY 45 188 0.001016 0.007099
134 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 8 16 0.001137 0.007883
135 CHEMOREPELLENT ACTIVITY 11 27 0.001182 0.008131
136 METALLOENDOPEPTIDASE ACTIVITY 30 113 0.001213 0.008285
137 SH3 SH2 ADAPTOR ACTIVITY 17 52 0.001224 0.0083
138 PROTEASE BINDING 28 104 0.001379 0.009285
139 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 9 20 0.001434 0.009585
NumGOOverlapSizeP ValueAdj. P Value
1 CELL PROJECTION 434 1786 1.738e-26 1.015e-23
2 NEURON PROJECTION 261 942 3.185e-24 9.301e-22
3 SYNAPSE 221 754 5.456e-24 1.062e-21
4 NEURON PART 324 1265 1.303e-23 1.903e-21
5 INTRINSIC COMPONENT OF PLASMA MEMBRANE 394 1649 1.589e-22 1.855e-20
6 EXTRACELLULAR MATRIX 144 426 3.292e-22 3.204e-20
7 PROTEINACEOUS EXTRACELLULAR MATRIX 127 356 5.086e-22 4.243e-20
8 CELL JUNCTION 296 1151 7.098e-22 5.181e-20
9 MEMBRANE REGION 290 1134 4.706e-21 3.053e-19
10 POSTSYNAPSE 123 378 1.187e-17 6.931e-16
11 EXTRACELLULAR MATRIX COMPONENT 58 125 1.051e-16 4.784e-15
12 SYNAPSE PART 171 610 1.065e-16 4.784e-15
13 PLASMA MEMBRANE PROTEIN COMPLEX 150 510 9.383e-17 4.784e-15
14 PLASMA MEMBRANE REGION 231 929 2.012e-15 8.393e-14
15 CELL SURFACE 197 757 2.223e-15 8.656e-14
16 ACTIN CYTOSKELETON 132 444 2.708e-15 9.882e-14
17 MEMBRANE MICRODOMAIN 95 288 2.384e-14 8.038e-13
18 CELL LEADING EDGE 109 350 2.477e-14 8.038e-13
19 SOMATODENDRITIC COMPARTMENT 171 650 6.029e-14 1.853e-12
20 EXCITATORY SYNAPSE 72 197 1.109e-13 3.239e-12
21 DENDRITE 129 451 1.348e-13 3.749e-12
22 CELL SUBSTRATE JUNCTION 117 398 2.458e-13 6.525e-12
23 ANCHORING JUNCTION 136 489 2.992e-13 7.596e-12
24 CYTOSKELETON 406 1967 4.291e-12 1.044e-10
25 I BAND 49 121 1.288e-11 3.009e-10
26 AXON 116 418 1.967e-11 4.417e-10
27 INTRACELLULAR VESICLE 275 1259 4.961e-11 1.073e-09
28 BASEMENT MEMBRANE 40 93 1.072e-10 2.235e-09
29 SIDE OF MEMBRANE 115 428 2.111e-10 4.251e-09
30 RECEPTOR COMPLEX 93 327 4.82e-10 9.382e-09
31 CELL PROJECTION PART 213 946 5.848e-10 1.102e-08
32 CONTRACTILE FIBER 67 211 9.535e-10 1.74e-08
33 GOLGI APPARATUS 301 1445 1.36e-09 2.406e-08
34 SYNAPTIC MEMBRANE 77 261 2.475e-09 4.251e-08
35 ACTOMYOSIN 29 62 3.677e-09 6.135e-08
36 PLASMA MEMBRANE RAFT 35 86 9.01e-09 1.462e-07
37 EXTRINSIC COMPONENT OF MEMBRANE 73 252 1.491e-08 2.353e-07
38 SITE OF POLARIZED GROWTH 50 149 1.668e-08 2.563e-07
39 SARCOLEMMA 44 125 2.377e-08 3.559e-07
40 POSTSYNAPTIC MEMBRANE 62 205 3.126e-08 4.562e-07
41 CELL CELL JUNCTION 99 383 3.203e-08 4.562e-07
42 CELL CORTEX 69 238 3.536e-08 4.917e-07
43 FILOPODIUM 36 94 3.69e-08 5.011e-07
44 CYTOPLASMIC REGION 79 287 4.556e-08 6.047e-07
45 LAMELLIPODIUM 54 172 5.994e-08 7.778e-07
46 COMPLEX OF COLLAGEN TRIMERS 15 23 7.297e-08 9.264e-07
47 VACUOLE 244 1180 1.061e-07 1.319e-06
48 PLATELET ALPHA GRANULE 30 75 1.61e-07 1.958e-06
49 EXTRACELLULAR SPACE 277 1376 1.748e-07 2.083e-06
50 CELL BODY 118 494 1.799e-07 2.102e-06
51 COLLAGEN TRIMER 33 88 2.409e-07 2.759e-06
52 CYTOPLASMIC SIDE OF MEMBRANE 52 170 2.638e-07 2.963e-06
53 ACTIN BASED CELL PROJECTION 54 181 3.837e-07 4.228e-06
54 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 35 98 4.186e-07 4.527e-06
55 RUFFLE 48 156 6.178e-07 6.559e-06
56 ACTIN FILAMENT BUNDLE 24 57 9.062e-07 9.451e-06
57 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 43 136 1.037e-06 1.063e-05
58 MEMBRANE PROTEIN COMPLEX 209 1020 1.758e-06 1.77e-05
59 AXON PART 60 219 2.138e-06 2.116e-05
60 ENDOPLASMIC RETICULUM LUMEN 56 201 2.624e-06 2.53e-05
61 T TUBULE 20 45 2.642e-06 2.53e-05
62 NEURONAL POSTSYNAPTIC DENSITY 22 53 3.411e-06 3.213e-05
63 CYTOPLASMIC VESICLE PART 132 601 4.523e-06 4.193e-05
64 CATION CHANNEL COMPLEX 48 167 5.237e-06 4.779e-05
65 ACTIN FILAMENT 26 70 5.449e-06 4.896e-05
66 INTERCALATED DISC 21 51 6.604e-06 5.844e-05
67 PLATELET ALPHA GRANULE LUMEN 22 55 7.052e-06 6.146e-05
68 CELL CELL CONTACT ZONE 24 64 1.024e-05 8.796e-05
69 A BAND 16 34 1.077e-05 9.117e-05
70 GLYCOPROTEIN COMPLEX 12 21 1.114e-05 9.296e-05
71 PERINUCLEAR REGION OF CYTOPLASM 137 642 1.413e-05 0.0001146
72 SECRETORY VESICLE 104 461 1.405e-05 0.0001146
73 PLASMA MEMBRANE RECEPTOR COMPLEX 48 175 2.063e-05 0.0001628
74 ENDOSOME 163 793 2.039e-05 0.0001628
75 ENDOPLASMIC RETICULUM 306 1631 2.263e-05 0.0001762
76 PODOSOME 12 23 3.806e-05 0.0002925
77 INTERSTITIAL MATRIX 9 14 4.066e-05 0.0003084
78 CELL CORTEX PART 35 119 5.586e-05 0.0004182
79 LEADING EDGE MEMBRANE 38 134 6.609e-05 0.0004885
80 M BAND 11 21 7.71e-05 0.0005629
81 NEURON SPINE 35 121 8.128e-05 0.000586
82 SECRETORY GRANULE 80 352 0.0001012 0.0007151
83 PRESYNAPSE 67 283 0.0001016 0.0007151
84 CYTOSKELETAL PART 268 1436 0.0001079 0.0007498
85 EXTERNAL SIDE OF PLASMA MEMBRANE 58 238 0.0001264 0.0008686
86 EARLY ENDOSOME 70 301 0.0001289 0.0008755
87 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 13 30 0.0002058 0.001382
88 MAIN AXON 20 58 0.0002111 0.001401
89 NEUROMUSCULAR JUNCTION 19 54 0.0002236 0.001467
90 SECRETORY GRANULE LUMEN 26 85 0.0002427 0.001575
91 VESICLE MEMBRANE 107 512 0.0002724 0.001748
92 CELL PROJECTION MEMBRANE 68 298 0.0002854 0.001812
93 VOLTAGE GATED SODIUM CHANNEL COMPLEX 8 14 0.0003528 0.002215
94 APICAL PART OF CELL 79 361 0.0003934 0.002444
95 GOLGI APPARATUS PART 172 893 0.0004165 0.00256
96 TRANSPORTER COMPLEX 71 321 0.00055 0.003346
97 VACUOLAR PART 137 694 0.0005629 0.003389
98 APICAL JUNCTION COMPLEX 34 128 0.0005902 0.003517
99 CORTICAL ACTIN CYTOSKELETON 19 58 0.000629 0.003711
100 NEURON PROJECTION TERMINUS 34 129 0.0006865 0.004001
101 CORTICAL CYTOSKELETON 24 81 0.000692 0.004001
102 BANDED COLLAGEN FIBRIL 7 12 0.000718 0.004111
103 VESICLE LUMEN 29 106 0.0008683 0.004923
104 ANCHORED COMPONENT OF MEMBRANE 38 152 0.001031 0.005791
105 RUFFLE MEMBRANE 23 80 0.001392 0.00774
106 FILAMENTOUS ACTIN 9 20 0.001434 0.007901
107 POTASSIUM CHANNEL COMPLEX 25 90 0.001512 0.008253
108 ENDOCYTIC VESICLE 57 256 0.001555 0.008408
109 COATED PIT 20 67 0.001691 0.009059
110 SODIUM CHANNEL COMPLEX 8 17 0.001864 0.009808
111 GOLGI MEMBRANE 135 703 0.001864 0.009808

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Focal_adhesion_hsa04510 75 199 5.196e-15 2.702e-13
2 MAPK_signaling_pathway_hsa04010 97 295 1.593e-14 4.142e-13
3 cGMP_PKG_signaling_pathway_hsa04022 63 163 2.037e-13 3.531e-12
4 PI3K_Akt_signaling_pathway_hsa04151 106 352 6.213e-13 8.076e-12
5 Regulation_of_actin_cytoskeleton_hsa04810 65 208 3.475e-09 3.614e-08
6 Ras_signaling_pathway_hsa04014 70 232 4.628e-09 4.011e-08
7 FoxO_signaling_pathway_hsa04068 46 132 1.647e-08 1.224e-07
8 cAMP_signaling_pathway_hsa04024 61 198 1.888e-08 1.227e-07
9 ECM_receptor_interaction_hsa04512 33 82 3.294e-08 1.903e-07
10 Rap1_signaling_pathway_hsa04015 62 206 3.818e-08 1.985e-07
11 Apelin_signaling_pathway_hsa04371 46 137 6.019e-08 2.845e-07
12 Phospholipase_D_signaling_pathway_hsa04072 48 146 6.595e-08 2.858e-07
13 Wnt_signaling_pathway_hsa04310 47 146 1.836e-07 7.343e-07
14 Sphingolipid_signaling_pathway_hsa04071 40 118 3.215e-07 1.194e-06
15 Hippo_signaling_pathway_hsa04390 48 154 4.045e-07 1.402e-06
16 Calcium_signaling_pathway_hsa04020 54 182 4.66e-07 1.514e-06
17 Cytokine_cytokine_receptor_interaction_hsa04060 72 270 6.644e-07 2.032e-06
18 Cell_adhesion_molecules_.CAMs._hsa04514 45 145 1.051e-06 3.035e-06
19 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 43 139 1.985e-06 5.357e-06
20 Jak_STAT_signaling_pathway_hsa04630 48 162 2.06e-06 5.357e-06
21 TGF_beta_signaling_pathway_hsa04350 30 84 2.742e-06 6.79e-06
22 Cellular_senescence_hsa04218 46 160 8.086e-06 1.911e-05
23 Adherens_junction_hsa04520 24 72 9.481e-05 0.0002144
24 Phagosome_hsa04145 41 152 0.0001195 0.0002589
25 Gap_junction_hsa04540 27 88 0.0001758 0.0003657
26 AMPK_signaling_pathway_hsa04152 34 121 0.0001892 0.0003783
27 ErbB_signaling_pathway_hsa04012 26 85 0.0002427 0.0004674
28 Tight_junction_hsa04530 43 170 0.0003857 0.0007162
29 TNF_signaling_pathway_hsa04668 30 108 0.0005421 0.000972
30 Phosphatidylinositol_signaling_system_hsa04070 27 99 0.001352 0.002344
31 HIF_1_signaling_pathway_hsa04066 27 100 0.001589 0.002666
32 Hippo_signaling_pathway_multiple_species_hsa04392 11 29 0.002342 0.003806
33 Oocyte_meiosis_hsa04114 31 124 0.002846 0.004485
34 mTOR_signaling_pathway_hsa04150 36 151 0.003285 0.005024
35 Neuroactive_ligand_receptor_interaction_hsa04080 56 278 0.01472 0.02106
36 Endocytosis_hsa04144 50 244 0.01494 0.02106
37 Mitophagy_animal_hsa04137 17 65 0.01498 0.02106
38 ABC_transporters_hsa02010 12 45 0.03246 0.04442
39 Apoptosis_hsa04210 29 138 0.04003 0.05338
40 Hedgehog_signaling_pathway_hsa04340 12 47 0.04429 0.05758
41 VEGF_signaling_pathway_hsa04370 14 59 0.05508 0.06986
42 Autophagy_animal_hsa04140 26 128 0.07028 0.08702
43 NF_kappa_B_signaling_pathway_hsa04064 20 95 0.07655 0.09257
44 p53_signaling_pathway_hsa04115 15 68 0.08283 0.09789
45 Necroptosis_hsa04217 31 164 0.1116 0.1289
46 Ferroptosis_hsa04216 9 40 0.1422 0.1608
47 Apoptosis_multiple_species_hsa04215 6 33 0.3848 0.4257
48 Lysosome_hsa04142 20 123 0.4053 0.4391
49 Notch_signaling_pathway_hsa04330 8 48 0.4464 0.4738
50 Cell_cycle_hsa04110 19 124 0.5196 0.5404
51 Autophagy_other_hsa04136 3 32 0.8834 0.8999
52 Peroxisome_hsa04146 9 83 0.8999 0.8999

Quest ID: 428b732fe7ec32853e84733e8eb3dbd9